{"content":"<li class=\"n-box-item date-title\" data-end=\"1571457599\" data-start=\"1571371200\" data-txt=\"Monday, December 23, 2019\">Friday, October 18, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3507075\" data-ts=\"1571435717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3507075-mnk-endp-yndx-and-among-notable-after-hours-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MNK, ENDP, YNDX and AM among notable after hours movers</a></h4><ul><li><b>Gainers</b><strong>:</strong> <a href='https://seekingalpha.com/symbol/YNDX' title='Yandex N.V.'>YNDX</a> <font color=\"green\">+3.5%</font>.<b> </b><a href='https://seekingalpha.com/symbol/FOMX' title='Foamix Pharmaceuticals Ltd.'>FOMX</a> <font color=\"green\">+2.6%</font>. <a href='https://seekingalpha.com/symbol/AM' title='Antero Midstream Corporation'>AM</a> <font color=\"green\">+2.6%</font>. <a href='https://seekingalpha.com/symbol/RVNC' title='Revance Therapeutics, Inc.'>RVNC</a> <font color=\"green\">+1.8%</font>. <a href='https://seekingalpha.com/symbol/DERM' title='Dermira, Inc.'>DERM</a> <font color=\"green\">+1%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/KWR' title='Quaker Chemical Corporation'>KWR</a> <font color=\"red\">-6.9%</font>.  <a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt plc'>MNK</a> <font color=\"red\">-3.4%</font>. <a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color=\"red\">-2.8%</font>.<a href='https://seekingalpha.com/symbol/ARDX' title='Ardelyx, Inc.'>ARDX</a> <font color=\"red\">-2.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3507075\" data-linked=\"MNK, ENDP, YNDX and AM among notable after hours movers\" data-tweet=\"$YNDX $FOMX $AM - MNK, ENDP, YNDX and AM among notable after hours movers https://seekingalpha.com/news/3507075-mnk-endp-yndx-and-among-notable-after-hours-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3507075-mnk-endp-yndx-and-among-notable-after-hours-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3507076\" data-ts=\"1571435651\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3507076-huge-opioid-settlement-hits-late-snag\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Huge opioid settlement hits late snag</a></h4><ul>   <li>The first federal case in the opioid crisis seems headed to trial Monday after an 11th-hour settlement <a href=\"https://www.washingtonpost.com/health/high-profile-opioid-settlement-talks-hit-snags/2019/10/18/79709c3e-f1ae-11e9-8693-f487e46784aa_story.html\" target=\"_blank\">appeared to be breaking down</a>.</li>    <li>A $50B bid from four state AGs and corporate executives to settle hundreds of lawsuits and head off the federal trial faced opposition from local officials.</li>    <li>There's been no progress in getting three distributors -- McKesson (NYSE:<a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a>), Cardinal Health (NYSE:<a href='https://seekingalpha.com/symbol/CAH' title='Cardinal Health, Inc.'>CAH</a>) and AmerisourceBergen (NYSE:<a href='https://seekingalpha.com/symbol/ABC' title='AmerisourceBergen Corporation'>ABC</a>) -- to boost a settlement offer from $18B over 18 years, according to the lead attorney for 2,400 cities and counties.</li>    <li>And Teva (NYSE:<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>) isn't budging from its offer of a few hundred million dollars plus anti-addiction drugs, and there's been little negotiation with Walgreens (NASDAQ:<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a>), he says.</li><li>Johnson &amp; Johnson (NYSE:<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a>) has agreed to contribute $4B over a shorter time frame.</li>    <li>After hours: <a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a> <font color=\"red\">-3.1%</font>; <a href='https://seekingalpha.com/symbol/CAH' title='Cardinal Health, Inc.'>CAH</a> <font color=\"red\">-3%</font>; <a href='https://seekingalpha.com/symbol/ABC' title='AmerisourceBergen Corporation'>ABC</a> <font color=\"red\">-1.8%</font>; <a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a> <font color=\"red\">-0.4%</font>; <a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color=\"green\">+0.1%</font>; <a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color=\"red\">-2.4%</font>; <a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color=\"red\">-1.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3507076\" data-linked=\"Huge opioid settlement hits late snag\" data-tweet=\"$MCK $CAH $ABC - Huge opioid settlement hits late snag https://seekingalpha.com/news/3507076-huge-opioid-settlement-hits-late-snag?source=tweet\" data-url=\"https://seekingalpha.com/news/3507076-huge-opioid-settlement-hits-late-snag\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>259&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3507059\" data-ts=\"1571430905\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3507059-vxx-ung-mj-and-ugaz-among-notable-etf-movers-5-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VXX, UNG, MJ and UGAZ among notable ETF movers (5-Day)</a></h4><ul><li><strong>Gainers: </strong>Direxion Natural Gas Bear 3X (NYSEARCA:<a href='https://seekingalpha.com/symbol/GASX' title='Direxion Daily Natural Gas Related Bear 3X Shares ETF'>GASX</a>) <font color=\"green\">+14.6%</font>.</li><li>Direxion Homebuild &amp; Suppliers Bull 3X (NYSEARCA:<a href='https://seekingalpha.com/symbol/NAIL' title='Direxion Daily Homebuilders & Supplies Bull 3x Shares ETF'>NAIL</a>) <font color=\"green\">+14.5%</font>.</li><li>Direxion Daily Pharmaceutical &amp; Medical Bull 3X (NYSEARCA:<a href='https://seekingalpha.com/symbol/PILL' title='Direxion Shares ETF Trust - Direxion Daily Pharmaceutical & Medical Bull 3X Shares'>PILL</a>) <font color=\"green\">+13.7%</font>.</li><li>Direxion S&amp;P Oil &amp; Gas Expl Bear 3X (NYSEARCA:<a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>) <font color=\"green\">+10.6%</font>.</li><li>Natural Gas 3X Long ETN Velocityshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>) <font color=\"green\">+10.0%</font>.</li><li><strong>Losers: </strong>VS 2X VIX Short Term (NASDAQ:<a href='https://seekingalpha.com/symbol/TVIX' title='VelocityShares Daily 2x VIX Short-Term ETN'>TVIX</a>) <font color=\"red\">-15.1%</font>.</li><li>Natural Gas Bull 3X Direxion (NYSEARCA:<a href='https://seekingalpha.com/symbol/GASL' title='Direxion Daily Natural Gas Related Bull 3x Shares ETF'>GASL</a>) <font color=\"red\">-14.2%</font>.</li><li>Ultra VIX Short-Term Fut Proshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/UVXY' title='ProShares Ultra VIX Short-Term Futures ETF'>UVXY</a>) <font color=\"red\">-12.0%</font>.</li><li>Direxion S&amp;P Oil &amp; Gas Expl Bull 3X (NYSEARCA:<a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>) <font color=\"red\">-10.6%</font>.</li><li>Natural Gas -3X Inverse ETN Velocityshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>) <font color=\"red\">-9.9%</font>.</li><li><strong>Top non-leveraged gainers: </strong>US Healthcare Providers Ishares ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/IHF' title='iShares U.S. Healthcare Providers ETF'>IHF</a>) <font color=\"green\">+6.2%</font>.</li><li>US Natural Gas Fund (NYSEARCA:<a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>) <font color=\"green\">+5.5%</font>.</li><li>Alternative Harvest ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/MJ' title='ETFMG Alternative Harvest ETF'>MJ</a>) <font color=\"green\">+5.0%</font>.</li><li>India Consumer Egshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/INCO' title='Columbia ETF Trust II - Columbia India Consumer ETF'>INCO</a>) <font color=\"green\">+5.0%</font>.</li><li>S&amp;P Pharmaceuticals SPDR (NYSEARCA:<a href='https://seekingalpha.com/symbol/XPH' title='SPDR S&P Pharmaceuticals ETF'>XPH</a>) <font color=\"green\">+5.00%</font>.</li><li><strong>Top non-leveraged losers: </strong>VIX Short-Term Futures Proshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/VIXY' title='ProShares VIX Short-Term Futures ETF'>VIXY</a>) <font color=\"red\">-8.3%</font>.</li><li>VS VIX Short Term (NASDAQ:<a href='https://seekingalpha.com/symbol/VIIX' title='VelocityShares VIX Short-Term ETN'>VIIX</a>) <font color=\"red\">-8.2%</font>.</li><li>Ipath.B S&amp;P 500 VIX Short-Term Futures ETN (BATS:<a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a>) <font color=\"red\">-8.1%</font>.</li><li>S&amp;P Smallcap Energy Invesco ETF (NASDAQ:<a href='https://seekingalpha.com/symbol/PSCE' title='Invesco Exchange-Traded Fund Trust II - Invesco S&P SmallCap Energy ETF'>PSCE</a>) <font color=\"red\">-5.7%</font>.</li><li>Natural Gas ETF FT (NYSEARCA:<a href='https://seekingalpha.com/symbol/FCG' title='First Trust Natural Gas ETF'>FCG</a>)<font color=\"red\"> -4.8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3507059\" data-linked=\"VXX, UNG, MJ and UGAZ among notable ETF movers (5-Day)\" data-tweet=\"$GASX $NAIL $PILL - VXX, UNG, MJ and UGAZ among notable ETF movers (5-Day) https://seekingalpha.com/news/3507059-vxx-ung-mj-and-ugaz-among-notable-etf-movers-5-day?source=tweet\" data-url=\"https://seekingalpha.com/news/3507059-vxx-ung-mj-and-ugaz-among-notable-etf-movers-5-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3507058\" data-ts=\"1571430852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3507058-msft-orcl-vmw-defensible-stocks-bmo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MSFT, ORCL, VMW most defensible stocks - BMO</a></h4><ul><li>BMO says software valuations are still elevated compared to historical trends and further macro deterioration could add more pressure.</li><li>If the economic deterioration does happen, BMO sees Microsoft (NASDAQ:<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a>), Oracle (NYSE:<a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a>), and VMware (NYSE:<a href='https://seekingalpha.com/symbol/VMW' title='VMware, Inc.'>VMW</a>) as having the \"most defensible\" valuations, Atlassian (NASDAQ:<a href='https://seekingalpha.com/symbol/TEAM' title='Atlassian Corporation Plc'>TEAM</a>) as the most defensible business model, and reiterates Salesforce (NYSE:<a href='https://seekingalpha.com/symbol/CRM' title='salesforce.com, inc.'>CRM</a>) as a top pick.</li><li>Related: Atlassian's mostly in-line FY guidance yesterday <a href=\"https://seekingalpha.com/news/3506970-atlassian-print-leads-software-stocks-lower\" target=\"_blank\">led </a>software stocks into the red.</li></ul><div class=\"tiny-share-widget\" data-id=\"3507058\" data-linked=\"MSFT, ORCL, VMW most defensible stocks - BMO\" data-tweet=\"$MSFT $ORCL $VMW - MSFT, ORCL, VMW most defensible stocks - BMO https://seekingalpha.com/news/3507058-msft-orcl-vmw-defensible-stocks-bmo?source=tweet\" data-url=\"https://seekingalpha.com/news/3507058-msft-orcl-vmw-defensible-stocks-bmo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3507048\" data-ts=\"1571429481\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOMX\" target=\"_blank\">FOMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3507048-fda-oks-foamix-topical-acne-foam\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OK&#39;s Foamix topical acne foam</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17667651-foamix-receives-fda-approval-amzeeq-topical-minocycline-treatment-millions-moderate-severe\" target=\"_blank\">approves</a> Foamix Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/FOMX' title='Foamix Pharmaceuticals Ltd.'>FOMX</a>) AMZEEQ (minocycline) topical foam, 4% (formerly FMX101) for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients at least nine years old.</li><li><strong>Update</strong>: Shares, currently halted, will resume trading at 4:40 pm ET.</li></ul><div class=\"tiny-share-widget\" data-id=\"3507048\" data-linked=\"FDA OK&#39;s Foamix topical acne foam\" data-tweet=\"$FOMX - FDA OK&#39;s Foamix topical acne foam https://seekingalpha.com/news/3507048-fda-oks-foamix-topical-acne-foam?source=tweet\" data-url=\"https://seekingalpha.com/news/3507048-fda-oks-foamix-topical-acne-foam\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3507047\" data-ts=\"1571429453\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPRE\" target=\"_blank\">TPRE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3507047-third-point-reinsurance-gets-boost-after-report-reviewing-options\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Third Point Reinsurance gets boost after report it&#39;s reviewing options</a></h4><ul><li>Third Point Reinsurance (NYSE:<a href='https://seekingalpha.com/symbol/TPRE' title='Third Point Reinsurance Ltd.'>TPRE</a>) <font color=\"green\">jumps 2.2% </font>after Insurance Insider reports tha<a href=\"https://www.insuranceinsider.com/articles/129514/third-point-re-working-with-jp-morgan-as-it-reviews-options\" target=\"_blank\">t TPRE is working </a>with JPMorgan to review alternatives, including acquisitions and mergers.</li></ul><div class=\"tiny-share-widget\" data-id=\"3507047\" data-linked=\"Third Point Reinsurance gets boost after report it&#39;s reviewing options\" data-tweet=\"$TPRE - Third Point Reinsurance gets boost after report it&#39;s reviewing options https://seekingalpha.com/news/3507047-third-point-reinsurance-gets-boost-after-report-reviewing-options?source=tweet\" data-url=\"https://seekingalpha.com/news/3507047-third-point-reinsurance-gets-boost-after-report-reviewing-options\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3507037\" data-ts=\"1571427984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLGT\" target=\"_blank\">TLGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3507037-fda-oks-teligent-gentamicin-cream-shares-up-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Teligent gentamicin cream; shares up 14%</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17667616-teligent-inc-announces-fda-approval-gentamicin-sulfate-cream-usp-0_1-percent-gentamicin-base\" target=\"_blank\">approves </a>Teligent's (<a href='https://seekingalpha.com/symbol/TLGT' title='Teligent, Inc.'>TLGT</a> <font color=\"green\">+13.7%</font>) Gentamicin Sulfate Cream USP, 0.1%.</li><li>Per IQVIA, the U.S. market is ~$15.6M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3507037\" data-linked=\"FDA OKs Teligent gentamicin cream; shares up 14%\" data-tweet=\"$TLGT - FDA OKs Teligent gentamicin cream; shares up 14% https://seekingalpha.com/news/3507037-fda-oks-teligent-gentamicin-cream-shares-up-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3507037-fda-oks-teligent-gentamicin-cream-shares-up-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3507034\" data-ts=\"1571427426\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVR\" target=\"_blank\">NVR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3507034-nvrplus-2_3-q3-beats-on-11-rise-in-new-orders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NVR +2.3% as Q3 beats on 11% rise in new orders</a></h4><ul><li>NVR (NYSE:<a href='https://seekingalpha.com/symbol/NVR' title='NVR, Inc.'>NVR</a>) gains 2.3% after <a href=\"https://seekingalpha.com/pr/17667354-nvr-inc-announces-third-quarter-results\" target=\"_blank\">Q3 EPS </a>beat the average analyst estimate of $51.52 and rose from $48.28 in the year-ago quarter.</li><li>Q3 consolidated revenue of $1.91B exceeded the 1.84B consensus estimate and increased 3% from $1.85B in the year-ago quarter.</li><li>Q3 new orders rose 11% Y/Y to 4,766 units, while the average sales price of new orders fell 1% to $369,200.</li><li>Q3 homebuilding revenue of $1.87B rose 4% Y/Y; gross profit margin increased to 19.0% vs. 18.6% a year ago.</li><li>Q3 mortgage loan production was $1.37B, up 10% Y/Y.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3506897-nvr-eps-beats-4_59-beats-revenue\" target=\"_blank\">NVR EPS beats by $4.59, beats on revenue</a> (Oct. 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3507034\" data-linked=\"NVR +2.3% as Q3 beats on 11% rise in new orders\" data-tweet=\"$NVR - NVR +2.3% as Q3 beats on 11% rise in new orders https://seekingalpha.com/news/3507034-nvrplus-2_3-q3-beats-on-11-rise-in-new-orders?source=tweet\" data-url=\"https://seekingalpha.com/news/3507034-nvrplus-2_3-q3-beats-on-11-rise-in-new-orders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3507027\" data-ts=\"1571426710\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLY\" target=\"_blank\">NLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3507027-annaly-bounces-after-bill-gross-mention\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Annaly bounces after Bill Gross mention</a></h4><ul><li>Annaly Capital Management (<a href='https://seekingalpha.com/symbol/NLY' title='Annaly Capital Management, Inc.'>NLY</a> <font color=\"green\">+1.6%</font>) took a bump up in afternoon trading after Bill Gross said he's <a href=\"https://www.cnbc.com/video/2019/10/18/gross-trump-wont-be-reelected-warren-will-be-democratic-candidate.html\" target=\"_blank\">buying the stock </a>as it appears the 2s-10s yield spread will widen.</li><li>The Fed's move to buy Treasury bills should widen the yield curve, which bodes well for mortgage REITs and banks, he said in an interview on CNBC.</li><li>\"I'm in there for the yield,\" he said. \"I like high dividend-paying stocks.\"</li><li>Invesco (<a href='https://seekingalpha.com/symbol/IVZ' title='Invesco Ltd.'>IVZ</a> <font color=\"green\">+1.6%</font>) is another stock that he likes.</li><li>Gross, who co-founded Pimco, retired from Janus Henderson in March.</li><li>Among other stocks mentioned in the interview: Gross sold his Dominion (<a href='https://seekingalpha.com/symbol/D' title='Dominion Energy, Inc.'>D</a> <font color=\"red\">-0.1%</font>) shares and thinks there's an arbritrage opportunity with AbbVie's (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color=\"green\">+2.1%</font>). PPL (<a href='https://seekingalpha.com/symbol/PPL' title='PPL Corporation'>PPL</a> <font color=\"red\">-0.1%</font>) is as \"good play on Brexit,\" he said.</li></ul><div class=\"tiny-share-widget\" data-id=\"3507027\" data-linked=\"Annaly bounces after Bill Gross mention\" data-tweet=\"$NLY $IVZ $D - Annaly bounces after Bill Gross mention https://seekingalpha.com/news/3507027-annaly-bounces-after-bill-gross-mention?source=tweet\" data-url=\"https://seekingalpha.com/news/3507027-annaly-bounces-after-bill-gross-mention\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>89&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3507026\" data-ts=\"1571426604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3507026-micro-focusplus-6_8-after-takeover-interest-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micro Focus +6.8% after takeover interest - Bloomberg</a></h4><ul><li>Micro Focus (NYSE:<a href='https://seekingalpha.com/symbol/MFGP' title='Micro Focus International plc'>MFGP</a>) <font color=\"green\">gains 6.8%</font> after <a href=\"https://www.bloomberg.com/news/articles/2019-10-18/open-text-is-said-to-weigh-takeover-offer-for-rival-micro-focus\" target=\"_blank\">Bloomberg reports</a> that Open Text (NASDAQ:<a href='https://seekingalpha.com/symbol/OTEX' title='Open Text Corporation'>OTEX</a>) is considering a takeover bid.</li><li>Open Text is speaking with potential advisors while Micro Focus conducts a strategic review that include a sale.</li><li>No final decisions have been made and the details could change.</li><li>OTEX shares are <font color=\"red\">down 3.3%</font>.</li><li>Post updated with additional details.</li></ul><div class=\"tiny-share-widget\" data-id=\"3507026\" data-linked=\"Micro Focus +6.8% after takeover interest - Bloomberg\" data-tweet=\"$MFGP $OTEX - Micro Focus +6.8% after takeover interest - Bloomberg https://seekingalpha.com/news/3507026-micro-focusplus-6_8-after-takeover-interest-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3507026-micro-focusplus-6_8-after-takeover-interest-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3507025\" data-ts=\"1571426468\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOMX\" target=\"_blank\">FOMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3507025-foamix-shares-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Foamix shares halted pending news</a></h4><ul><li>Nasdaq has suspended trading in Foamix Pharmaceuticals (<a href='https://seekingalpha.com/symbol/FOMX' title='Foamix Pharmaceuticals Ltd.'>FOMX</a> <font color=\"red\">-2.5%</font>) pending the release of news. In this case, it pertains to the FDA's expected decision on its application for acne foam FMX101 today (the actual PDUFA date is Sunday, October 20).</li></ul><div class=\"tiny-share-widget\" data-id=\"3507025\" data-linked=\"Foamix shares halted pending news\" data-tweet=\"$FOMX - Foamix shares halted pending news https://seekingalpha.com/news/3507025-foamix-shares-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3507025-foamix-shares-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3507024\" data-ts=\"1571426163\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PUMP\" target=\"_blank\">PUMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3507024-sec-probes-propetro-over-accounting-disclosures-reuters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SEC probes ProPetro over accounting, disclosures - Reuters</a></h4><ul><li>ProPetro (<a href='https://seekingalpha.com/symbol/PUMP' title='ProPetro Holding Corp.'>PUMP</a> <font color='red'>-9.3%</font>) plunges following a Reuters headline that the company is <a href=\"https://www.reuters.com/article/us-propetro-investigation-exclusive/exclusive-sec-probes-oilfield-firm-propetro-over-accounting-disclosures-sources-idUSKBN1WX2EX\" target=\"_blank\">under SEC investigation</a> over its financial accounting and disclosures.</li><li>The probe involves potential violations of securities laws covering disclosures, internal financial controls and public reporting, according to the report.</li><li>PUMP has been <a href=\"https://seekingalpha.com/news/3504879-propetro-unveils-management-shakeup-internal-probe\" target=\"_blank\">conducting its own investigation</a> into equipment purchases and expense reimbursements, and recently said the review had not uncovered any matters that would require a restatement of past results.</li></ul><div class=\"tiny-share-widget\" data-id=\"3507024\" data-linked=\"SEC probes ProPetro over accounting, disclosures - Reuters\" data-tweet=\"$PUMP - SEC probes ProPetro over accounting, disclosures - Reuters https://seekingalpha.com/news/3507024-sec-probes-propetro-over-accounting-disclosures-reuters?source=tweet\" data-url=\"https://seekingalpha.com/news/3507024-sec-probes-propetro-over-accounting-disclosures-reuters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3507019\" data-ts=\"1571424955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3507019-exfo-lpsn-and-work-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EXFO, LPSN and WORK among tech movers</a></h4><ul><li><strong>Gainers: </strong>Mer Telemanagement Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/MTSL' title='Mer Telemanagement Solutions Ltd.'>MTSL</a>) <font color=\"green\">+17%</font>. Qumu Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/QUMU' title='Qumu Corporation'>QUMU</a>) <font color=\"green\">+14%</font>. EXFO (NASDAQ:<a href='https://seekingalpha.com/symbol/EXFO' title='EXFO Inc.'>EXFO</a>) <font color=\"green\">+10%</font>. inTEST Corporation (NYSEMKT:<a href='https://seekingalpha.com/symbol/INTT' title='inTEST Corporation'>INTT</a>) <font color=\"green\">+6%</font>. Aethlon Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/AEMD' title='Aethlon Medical, Inc.'>AEMD</a>) <font color=\"green\">+5%</font>.</li> <li><strong>Losers: </strong>SPI Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a>) <font color=\"red\">-10%</font>. Jianpu Technology (NYSE:<a href='https://seekingalpha.com/symbol/JT' title='Jianpu Technology Inc.'>JT</a>) <font color=\"red\">-9%</font>. Slack Technologies (NYSE:<a href='https://seekingalpha.com/symbol/WORK' title='Slack Technologies, Inc.'>WORK</a>) <font color=\"red\">-9%</font>. LivePerson (NASDAQ:<a href='https://seekingalpha.com/symbol/LPSN' title='LivePerson, Inc.'>LPSN</a>) <font color=\"red\">-9%</font>. Luokung Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/LKCO' title='Luokung Technology Corp.'>LKCO</a>) <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3507019\" data-linked=\"EXFO, LPSN and WORK among tech movers\" data-tweet=\"$MTSL $QUMU $EXFO - EXFO, LPSN and WORK among tech movers https://seekingalpha.com/news/3507019-exfo-lpsn-and-work-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3507019-exfo-lpsn-and-work-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3507016\" data-ts=\"1571424299\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOG\" target=\"_blank\">XOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3507016-colorado-to-enact-stricter-review-of-drilling-near-homes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Colorado to enact stricter review of drilling near homes</a></h4><ul><li>Colorado oil and gas producers trade in the red after the Colorado Department of Public Health and Environment releases a report finding i<a href=\"https://www.cpr.org/2019/10/17/colorado-health-department-finds-proximity-to-drilling-operations-may-increase-health-risks/\" target=\"_blank\">ncreased risk of benzene exposure</a> within 2K ft. of drill sites: <a href='https://seekingalpha.com/symbol/XOG' title='Extraction Oil & Gas, Inc.'>XOG</a> <font color=\"red\">-7.5%</font>, <a href='https://seekingalpha.com/symbol/SRCI' title='SRC Energy Inc.'>SRCI</a> <font color=\"red\">-7.2%</font>, <a href='https://seekingalpha.com/symbol/PDCE' title='PDC Energy, Inc.'>PDCE</a> <font color=\"red\">-6.5%</font>, <a href='https://seekingalpha.com/symbol/HPR' title='HighPoint Resources Corporation'>HPR</a> <font color=\"red\">-4%</font>, <a href='https://seekingalpha.com/symbol/SM' title='SM Energy Company'>SM</a> <font color=\"red\">-3.6%</font>, <a href='https://seekingalpha.com/symbol/BCEI' title='Bonanza Creek Energy, Inc.'>BCEI</a> <font color=\"red\">-2.4%</font>, <a href='https://seekingalpha.com/symbol/NBL' title='Noble Energy, Inc.'>NBL</a> <font color=\"red\">-2%</font>, <a href='https://seekingalpha.com/symbol/WLL' title='Whiting Petroleum Corporation'>WLL</a> <font color=\"red\">-1.5%</font>.</li><li>The study examined well pads that are in pre-production, including drilling, fracking and flowback, not well pads that are  currently producing oil and gas.</li><li>In response, the head of the Colorado Oil and Gas Conservation Commission says the group will \"immediately enact stricter and safer  precautionary review measures to protect public health, safety, welfare,  the environment and wildlife.\"</li><li>Current state law prohibits oil and gas facilities from being  closer than 500 ft. from homes and 1K ft. from schools, health care  centers and other high-occupancy buildings.</li></ul><div class=\"tiny-share-widget\" data-id=\"3507016\" data-linked=\"Colorado to enact stricter review of drilling near homes\" data-tweet=\"$XOG $SRCI $PDCE - Colorado to enact stricter review of drilling near homes https://seekingalpha.com/news/3507016-colorado-to-enact-stricter-review-of-drilling-near-homes?source=tweet\" data-url=\"https://seekingalpha.com/news/3507016-colorado-to-enact-stricter-review-of-drilling-near-homes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3507014\" data-ts=\"1571422520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBR\" target=\"_blank\">EBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3507014-eletrobras-privatization-bill-set-for-early-november-reuters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eletrobras privatization bill set for early November - Reuters</a></h4><ul><li>Eletrobras (<a href='https://seekingalpha.com/symbol/EBR' title='Centrais Elétricas Brasileiras S.A. - Eletrobrás'>EBR</a> <font color='green'>+6%</font>) shares surge on renewed privatization hopes, as Reuters reports Brazil's Congress could <a href=\"https://www.reuters.com/article/us-eletrobras-privatization-minister/eletrobras-privatization-bill-to-be-set-in-motion-by-early-november-minister-idUSKBN1WX1X3\" target=\"_blank\">evaluate a privatization bill</a> early next month.</li><li>\"I plan to deliver this project to Congress in person,\" says minister Bento Albuquerque, who previously said the bill would be sent to Congress in October.</li></ul><div class=\"tiny-share-widget\" data-id=\"3507014\" data-linked=\"Eletrobras privatization bill set for early November - Reuters\" data-tweet=\"$EBR - Eletrobras privatization bill set for early November - Reuters https://seekingalpha.com/news/3507014-eletrobras-privatization-bill-set-for-early-november-reuters?source=tweet\" data-url=\"https://seekingalpha.com/news/3507014-eletrobras-privatization-bill-set-for-early-november-reuters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3507011\" data-ts=\"1571421691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3507011-sierra-metals-and-holly-energy-partners-among-energy-materials-gainers-key-energy-services\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sierra Metals and Holly Energy Partners among Energy/Materials gainers; Key Energy Services and Ring Energy among losers</a></h4><ul><li><b>Gainers: </b>Sierra Metals (NYSEMKT:<a href='https://seekingalpha.com/symbol/SMTS' title='Sierra Metals Inc.'>SMTS</a>) <font color=\"green\">+21%</font>. Holly Energy Partners (NYSE:<a href='https://seekingalpha.com/symbol/HEP' title='Holly Energy Partners, L.P.'>HEP</a>) <font color=\"green\">+10%</font>. Contango Oil &amp; Gas (NYSEMKT:<a href='https://seekingalpha.com/symbol/MCF' title='Contango Oil & Gas Company'>MCF</a>) <font color=\"green\">+9%</font>. Insteel Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/IIIN' title='Insteel Industries, Inc.'>IIIN</a>) <font color=\"green\">+6%</font>. Pacific Coast Oil Trust (NYSE:<a href='https://seekingalpha.com/symbol/ROYT' title='Pacific Coast Oil Trust'>ROYT</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"red\">-9%</font>. Ring Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/REI' title='Ring Energy, Inc.'>REI</a>) <font color=\"red\">-9%</font>. Antero Resources (NYSE:<a href='https://seekingalpha.com/symbol/AR' title='Antero Resources Corporation'>AR</a>) <font color=\"red\">-9%</font>. CARBO Ceramics (NYSE:<a href='https://seekingalpha.com/symbol/CRR' title='CARBO Ceramics Inc.'>CRR</a>) <font color=\"red\">-8%</font>. SRC Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/SRCI' title='SRC Energy Inc.'>SRCI</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3507011\" data-linked=\"Sierra Metals and Holly Energy Partners among Energy/Materials gainers; Key Energy Services and Ring Energy among losers\" data-tweet=\"$SMTS $HEP $MCF - Sierra Metals and Holly Energy Partners among Energy/Materials gainers; Key Energy Services and Ring Energy among losers https://seekingalpha.com/news/3507011-sierra-metals-and-holly-energy-partners-among-energy-materials-gainers-key-energy-services?source=tweet\" data-url=\"https://seekingalpha.com/news/3507011-sierra-metals-and-holly-energy-partners-among-energy-materials-gainers-key-energy-services\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3507004\" data-ts=\"1571420355\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACU\" target=\"_blank\">ACU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3507004-acme-united-reports-mixed-q3-results-and-updated-q4-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acme United reports mixed Q3 results and updated Q4 outlook</a></h4><ul><li>Acme United (<a href='https://seekingalpha.com/symbol/ACU' title='Acme United Corporation'>ACU</a> <font color='green'>+3.6%</font>) reports net sales rose 7% in <a href=\"https://seekingalpha.com/pr/17667317-acme-united-reports-7-percent-net-sales-increase-30-percent-diluted-eps-increase-third\" target=\"_blank\">Q3</a>.</li><li>Net sales in U.S. increased 6%; Europe advanced 15%; Canada grew 5%.</li><li>Gross margin rate down 30 bps to 35.5%.</li><li>Operating margin rate up 70 bps to 4.7%.</li><li>The company expects net sales of ~$142M vs. prior guidance range of $140M to $143M; net income of ~$5.2M vs. prior range of $5M to $5.3M; and earnings per share of ~$1.48 vs. prior range of $1.41 to $1.50.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3506892-acme-united-eps-beats-0_04-misses-revenue\" target=\"_blank\">Acme United EPS beats by $0.04, misses on revenue</a> (Oct. 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3507004\" data-linked=\"Acme United reports mixed Q3 results and updated Q4 outlook\" data-tweet=\"$ACU - Acme United reports mixed Q3 results and updated Q4 outlook https://seekingalpha.com/news/3507004-acme-united-reports-mixed-q3-results-and-updated-q4-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3507004-acme-united-reports-mixed-q3-results-and-updated-q4-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3507003\" data-ts=\"1571419788\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BYND\" target=\"_blank\">BYND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3507003-beyond-meatminus-6-on-bernstein-caution\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Beyond Meat -6% on Bernstein caution</a></h4><ul> <li>Beyond Meat (NASDAQ:<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a>) falls after Bernstein lowers its price target to $130 from $172 as it assigns a lower enterprise value to sales multiple to the alternative protein upstart.</li> <li>The firm also thinks investors will want to be reassured during the Beyond Meat earnings call on October 28 that new next-gen protein competition across the food sector won't slow down the company's growth projections.</li><li>BYND <font color=\"red\">-5.65%</font> to $110.32, the lowest level for shares since the early part of June.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3507003\" data-linked=\"Beyond Meat -6% on Bernstein caution\" data-tweet=\"$BYND - Beyond Meat -6% on Bernstein caution https://seekingalpha.com/news/3507003-beyond-meatminus-6-on-bernstein-caution?source=tweet\" data-url=\"https://seekingalpha.com/news/3507003-beyond-meatminus-6-on-bernstein-caution\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506995\" data-ts=\"1571418128\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506995-clearsign-combustion-and-ideal-power-among-industrial-gainers-losers-none\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ClearSign Combustion and Ideal Power among industrial gainers; Losers none</a></h4><ul><li><b>Gainers: </b>Attis Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/ATIS' title='Attis Industries, Inc.'>ATIS</a>) <font color=\"green\">+28%</font>. Ideal Power (NASDAQ:<a href='https://seekingalpha.com/symbol/IPWR' title='Ideal Power Inc.'>IPWR</a>) <font color=\"green\">+27%</font>. ClearSign Combustion (NASDAQ:<a href='https://seekingalpha.com/symbol/CLIR' title='ClearSign Combustion Corporation'>CLIR</a>) <font color=\"green\">+17%</font>. Air Industries (NYSEMKT:<a href='https://seekingalpha.com/symbol/AIRI' title='Air Industries Group'>AIRI</a>) <font color=\"green\">+8%</font>. The New Home Company (NYSE:<a href='https://seekingalpha.com/symbol/NWHM' title='The New Home Company Inc.'>NWHM</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>None</li></ul><div class=\"tiny-share-widget\" data-id=\"3506995\" data-linked=\"ClearSign Combustion and Ideal Power among industrial gainers; Losers none\" data-tweet=\"$ATIS $IPWR $CLIR - ClearSign Combustion and Ideal Power among industrial gainers; Losers none https://seekingalpha.com/news/3506995-clearsign-combustion-and-ideal-power-among-industrial-gainers-losers-none?source=tweet\" data-url=\"https://seekingalpha.com/news/3506995-clearsign-combustion-and-ideal-power-among-industrial-gainers-losers-none\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506994\" data-ts=\"1571417732\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506994-e-trade-financial-and-state-street-among-financial-gainers-bar-harbor-bankshares-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">E*TRADE Financial and State Street among financial gainers; Bar Harbor Bankshares leads losers</a></h4><ul><li><b>Gainers:</b> Altisource Asset Management (NYSEMKT:<a href='https://seekingalpha.com/symbol/AAMC' title='Altisource Asset Management Corporation'>AAMC</a>) <font color=\"green\">+6%</font>. State Street (NYSE:<a href='https://seekingalpha.com/symbol/STT' title='State Street Corporation'>STT</a>) <font color=\"green\">+6%</font>. E*TRADE Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/ETFC' title='E*TRADE Financial Corporation'>ETFC</a>) <font color=\"green\">+5%</font>. Drive Shack (NYSE:<a href='https://seekingalpha.com/symbol/DS' title='Drive Shack Inc.'>DS</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers:</b> Bar Harbor Bankshares (NYSEMKT:<a href='https://seekingalpha.com/symbol/BHB' title='Bar Harbor Bankshares'>BHB</a>) <font color=\"red\">-8%</font>. Pzena Investment Management (NYSE:<a href='https://seekingalpha.com/symbol/PZN' title='Pzena Investment Management, Inc'>PZN</a>) <font color=\"red\">-7%</font>. Innovative Industrial Properties (NYSE:<a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties, Inc.'>IIPR</a>) <font color=\"red\">-7%</font>. First Financial Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/FFBC' title='First Financial Bancorp.'>FFBC</a>) <font color=\"red\">-6%</font>. EverQuote (NASDAQ:<a href='https://seekingalpha.com/symbol/EVER' title='EverQuote, Inc.'>EVER</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506994\" data-linked=\"E*TRADE Financial and State Street among financial gainers; Bar Harbor Bankshares leads losers\" data-tweet=\"$AAMC $STT $ETFC - E*TRADE Financial and State Street among financial gainers; Bar Harbor Bankshares leads losers https://seekingalpha.com/news/3506994-e-trade-financial-and-state-street-among-financial-gainers-bar-harbor-bankshares-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3506994-e-trade-financial-and-state-street-among-financial-gainers-bar-harbor-bankshares-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506993\" data-ts=\"1571417606\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVTR\" target=\"_blank\">NVTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506993-nuvectra-up-19-on-advancement-of-virtis-application-in-u-s\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nuvectra up 19% on advancement of Virtis application in U.S.</a></h4><ul><li>Nano cap Nuvectra (<a href='https://seekingalpha.com/symbol/NVTR' title='Nuvectra Corporation'>NVTR</a> <font color=\"green\">+19.1%</font>) is up on a 9x surge in volume in reaction to its <a href=\"https://seekingalpha.com/pr/17667225-nuvectra-submits-chemical-composition-biocompatibility-data-fda-virtis\" target=\"_blank\">announcement </a>that it has submitted supplementary chemical composition and biocompatibility data to the FDA per its request related to the company's marketing application seeking approval of its Virtis Sacral Neuromodulation device for the treatment of chronic urinary retention and symptoms of overactive bladder.</li><li>It originally filed the application in February 2017 followed by an amendment in April 2018 but a decision from the FDA has been repeatedly <a href=\"https://seekingalpha.com/news/3367384-nuvectra-quite-marketing-applications-virtus-device-shares-3-percent-premarket\" target=\"_blank\">delayed</a> due to <a href=\"https://seekingalpha.com/news/3427239-fda-extends-action-date-nuvectras-virtis-snm-pma\" target=\"_blank\">requests</a> for additional data.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506993\" data-linked=\"Nuvectra up 19% on advancement of Virtis application in U.S.\" data-tweet=\"$NVTR - Nuvectra up 19% on advancement of Virtis application in U.S. https://seekingalpha.com/news/3506993-nuvectra-up-19-on-advancement-of-virtis-application-in-u-s?source=tweet\" data-url=\"https://seekingalpha.com/news/3506993-nuvectra-up-19-on-advancement-of-virtis-application-in-u-s\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506991\" data-ts=\"1571417429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506991-microcaps-mostly-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps mostly among midday movers</a></h4><ul><li><strong>Gainers: </strong>Bionano Genomics (NASDAQ:<a href='https://seekingalpha.com/symbol/BNGO' title='Bionano Genomics, Inc.'>BNGO</a>) <font color=\"green\">+85%</font>. Greenland Acquisition Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/GLAC' title='Greenland Acquisition Corporation'>GLAC</a>) <font color=\"green\">+52%</font>. Attis Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/ATIS' title='Attis Industries, Inc.'>ATIS</a>) <font color=\"green\">+31%</font>. Dermira (NASDAQ:<a href='https://seekingalpha.com/symbol/DERM' title='Dermira, Inc.'>DERM</a>) <font color=\"green\">+26%</font>. Nuvectra Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/NVTR' title='Nuvectra Corporation'>NVTR</a>) <font color=\"green\">+21%</font>. Mer Telemanagement Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/MTSL' title='Mer Telemanagement Solutions Ltd.'>MTSL</a>) <font color=\"green\">+18%</font>. ClearSign Combustion (NASDAQ:<a href='https://seekingalpha.com/symbol/CLIR' title='ClearSign Combustion Corporation'>CLIR</a>) <font color=\"green\">+18%</font>. Applied Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/APLT' title='Applied Therapeutics, Inc.'>APLT</a>) <font color=\"green\">+13%</font>. Ideal Power (NASDAQ:<a href='https://seekingalpha.com/symbol/IPWR' title='Ideal Power Inc.'>IPWR</a>) <font color=\"green\">+13%</font>. Sierra Metals (NYSEMKT:<a href='https://seekingalpha.com/symbol/SMTS' title='Sierra Metals Inc.'>SMTS</a>) <font color=\"green\">+12%</font>.</li> <li><strong>Losers: </strong>Gildan Activewear (NYSE:<a href='https://seekingalpha.com/symbol/GIL' title='Gildan Activewear Inc.'>GIL</a>) <font color=\"red\">-25%</font>. BIOLASE (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOL' title='BIOLASE, Inc.'>BIOL</a>) <font color=\"red\">-21%</font>. Navios Maritime Acquisition (NYSE:<a href='https://seekingalpha.com/symbol/NNA' title='Navios Maritime Acquisition Corporation'>NNA</a>) <font color=\"red\">-19%</font>. Synthesis Energy Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/SES' title='Synthesis Energy Systems, Inc.'>SES</a>) <font color=\"red\">-17%</font>. Hepion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/HEPA' title='Hepion Pharmaceuticals, Inc.'>HEPA</a>) <font color=\"red\">-14%</font>. HyreCar (NASDAQ:<a href='https://seekingalpha.com/symbol/HYRE' title='HyreCar Inc.'>HYRE</a>) <font color=\"red\">-13%</font>. Tyme Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a>) <font color=\"red\">-11%</font>. Mirati Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MRTX' title='Mirati Therapeutics, Inc.'>MRTX</a>) <font color=\"red\">-11%</font>. ENDRA Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NDRA' title='ENDRA Life Sciences Inc.'>NDRA</a>) <font color=\"red\">-11%</font>. JanOne (NASDAQ:<a href='https://seekingalpha.com/symbol/JAN' title='JanOne Inc.'>JAN</a>) <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506991\" data-linked=\"Microcaps mostly among midday movers\" data-tweet=\"$BNGO $GLAC $ATIS - Microcaps mostly among midday movers https://seekingalpha.com/news/3506991-microcaps-mostly-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3506991-microcaps-mostly-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506990\" data-ts=\"1571417340\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATHM\" target=\"_blank\">ATHM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506990-autohomeminus-2_2-alongside-clsa-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Autohome -2.2% alongside CLSA downgrade</a></h4><ul>   <li>Autohome ADRs (NYSE:<a href='https://seekingalpha.com/symbol/ATHM' title='Autohome Inc.'>ATHM</a>) are <font color=\"red\">off 2.2%</font> today following a cut to Outperform at CLSA.</li>    <li>Sell-side analysts rate it <a href=\"https://seekingalpha.com/symbol/ATHM/ratings/sell-side-ratings\" target=\"_blank\">Outperform on average</a>, and <a href=\"https://seekingalpha.com/symbol/ATHM/ratings/author-ratings\" target=\"_blank\">Seeking Alpha authors are Bullish overall</a>; it has a <a href=\"https://seekingalpha.com/symbol/ATHM/ratings/quant-ratings\" target=\"_blank\">Quant Rating of Neutral</a>.</li>    <li>The company's set to report earnings Nov. 7; consensus expectations are for EPS of $0.84 on revenues of $307.6M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506990\" data-linked=\"Autohome -2.2% alongside CLSA downgrade\" data-tweet=\"$ATHM - Autohome -2.2% alongside CLSA downgrade https://seekingalpha.com/news/3506990-autohomeminus-2_2-alongside-clsa-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3506990-autohomeminus-2_2-alongside-clsa-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506988\" data-ts=\"1571416404\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506988-boeing-drops-3_3-messages-suggest-faa-was-misled-on-max\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing drops 3.3% as messages suggest FAA was misled on MAX</a></h4><ul>   <li>Boeing (NYSE:<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a>) has made a sudden leg down, <font color=\"red\">-3.3%</font>, after word the FAA is demanding explanations on the 737 Max after instant messages Boeing found months ago suggested employees misled the agency about a key safety system.</li>    <li>\"Yesterday, Boeing alerted the Department of Transportation to the existence of instant messages between two Boeing employees, characterizing certain communications with the FAA during the original certification of the 737 MAX in 2016,\" the FAA says, according to media reports.</li>    <li>That's \"concerning,\" the agency says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506988\" data-linked=\"Boeing drops 3.3% as messages suggest FAA was misled on MAX\" data-tweet=\"$BA - Boeing drops 3.3% as messages suggest FAA was misled on MAX https://seekingalpha.com/news/3506988-boeing-drops-3_3-messages-suggest-faa-was-misled-on-max?source=tweet\" data-url=\"https://seekingalpha.com/news/3506988-boeing-drops-3_3-messages-suggest-faa-was-misled-on-max\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>381&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506977\" data-ts=\"1571414524\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506977-lifeway-foods-only-consumer-gainer-beyond-meat-and-gildan-activewear-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lifeway Foods only consumer gainer; Beyond Meat and Gildan Activewear among losers</a></h4><ul><li><b>Gainers: </b>Lifeway Foods (NASDAQ:<a href='https://seekingalpha.com/symbol/LWAY' title='Lifeway Foods, Inc.'>LWAY</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Gildan Activewear (NYSE:<a href='https://seekingalpha.com/symbol/GIL' title='Gildan Activewear Inc.'>GIL</a>) <font color=\"red\">-24%</font>. Beyond Meat (NASDAQ:<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a>) <font color=\"red\">-6%</font>. Forward Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/FORD' title='Forward Industries, Inc.'>FORD</a>) <font color=\"red\">-6%</font>. Coca-Cola FEMSA (NYSE:<a href='https://seekingalpha.com/symbol/KOF' title='Coca-Cola FEMSA, S.A.B. de C.V.'>KOF</a>) <font color=\"red\">-5%</font>. SunOpta (NASDAQ:<a href='https://seekingalpha.com/symbol/STKL' title='SunOpta Inc.'>STKL</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506977\" data-linked=\"Lifeway Foods only consumer gainer; Beyond Meat and Gildan Activewear among losers\" data-tweet=\"$LWAY $GIL $BYND - Lifeway Foods only consumer gainer; Beyond Meat and Gildan Activewear among losers https://seekingalpha.com/news/3506977-lifeway-foods-only-consumer-gainer-beyond-meat-and-gildan-activewear-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3506977-lifeway-foods-only-consumer-gainer-beyond-meat-and-gildan-activewear-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506973\" data-ts=\"1571413518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLIR\" target=\"_blank\">CLIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506973-clearsign-announces-engineering-order-from-exxonmobil\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ClearSign announces engineering order from ExxonMobil</a></h4><ul><li>ClearSign Combustion (<a href='https://seekingalpha.com/symbol/CLIR' title='ClearSign Combustion Corporation'>CLIR</a> <font color=\"green\">+19%</font>) has <a href=\"https://seekingalpha.com/pr/17667261-clearsign-combustion-corporation-receives-engineering-order-exxon-mobil-corporation\" target=\"_blank\">received</a> a Purchase Order from ExxonMobil to perform early engineering and installation planning regarding a trial installation of the company's ClearSign Core process burners at one of their Gulf Coast refineries.</li><li>\"This engineering order is one of the final steps prior to qualifying our ClearSign Core process burner technology for use in an ExxonMobil refinery, and is a significant milestone for our company in the process of demonstrating our technology with a supermajor at their facility\u201d, said Jim Deller, Ph.D, CEO of ClearSign.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506973\" data-linked=\"ClearSign announces engineering order from ExxonMobil\" data-tweet=\"$CLIR - ClearSign announces engineering order from ExxonMobil https://seekingalpha.com/news/3506973-clearsign-announces-engineering-order-from-exxonmobil?source=tweet\" data-url=\"https://seekingalpha.com/news/3506973-clearsign-announces-engineering-order-from-exxonmobil\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506972\" data-ts=\"1571413262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NE\" target=\"_blank\">NE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506972-noble-adds-two-rig-extensions-in-latest-fleet-status-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noble adds two rig extensions in latest fleet status report</a></h4><ul><li>Noble Corp. (<a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a> <font color=\"red\">-1.9%</font>) secured a contract extension for a  drillship in South America and another extension for a jack-up rig offshore U.K., according to its <a href=\"https://investors.noblecorp.com/static-files/de747912-278f-4b78-8e04-94416bfe2c99\" target=\"_blank\">latest quarterly fleet status report</a>.</li><li>NE says Apache exercised two of three option wells for the Noble Sam Croft drillship, extending the contract to March 2020.</li><li>Bassoe Offshore <a href=\"https://www.offshoreenergytoday.com/noble-secures-more-work-for-two-offshore-rigs/\" target=\"_blank\">estimates the dayrate</a> for the contract with Apache is $170K; the rig's previous dayrate  with W&amp;T in the Gulf of Mexico was estimated at $160K.</li><li>Also, Spirit Energy has exercised a final option for the Noble Hans Deul jack-up rig, extending the contract to April 2020; the rig currently is operating in the U.K. for an undisclosed dayrate.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506972\" data-linked=\"Noble adds two rig extensions in latest fleet status report\" data-tweet=\"$NE - Noble adds two rig extensions in latest fleet status report https://seekingalpha.com/news/3506972-noble-adds-two-rig-extensions-in-latest-fleet-status-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3506972-noble-adds-two-rig-extensions-in-latest-fleet-status-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506971\" data-ts=\"1571413028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506971-nokia-telia-building-network-biggest-nordic-shopping-center\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nokia, Telia building network at biggest Nordic shopping center</a></h4><ul>   <li>Nokia (<a href=\"http://seekingalpha.com/symbol/NOK\" target=\"_blank\">NOK</a> <font color=\"red\">-0.3%</font>) and Telia (<a href=\"http://seekingalpha.com/symbol/TLSNY\" target=\"_blank\">TLSNY</a> <font color=\"green\">+1.8%</font>) are launching a 5G network at Helsinki's new <a href=\"https://seekingalpha.com/pr/17667078-nokia-telia-launch-5g-network-largest-shopping-center-nordics\" target=\"_blank\">Mall of Tripla</a>, the biggest shopping center in the Nordic countries.</li>    <li>The intent is testing new retail and lifestyle experiences using Nokia's 5G base stations and small cells.</li>    <li>In store, retailers will be able to use AR and VR, facial and video recognition, and tailored in-store signage, the companies say, along with greater control over stock levels and supply chain, video analytics of customer behavior, and in-store robotics.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506971\" data-linked=\"Nokia, Telia building network at biggest Nordic shopping center\" data-tweet=\"$NOK $TLSNY $TLSNF - Nokia, Telia building network at biggest Nordic shopping center https://seekingalpha.com/news/3506971-nokia-telia-building-network-biggest-nordic-shopping-center?source=tweet\" data-url=\"https://seekingalpha.com/news/3506971-nokia-telia-building-network-biggest-nordic-shopping-center\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506970\" data-ts=\"1571412862\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506970-atlassian-print-leads-software-stocks-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atlassian print leads software stocks lower</a></h4><ul><li>Software stocks are seeing red after yesterday's Atlassian (<a href='https://seekingalpha.com/symbol/TEAM' title='Atlassian Corporation Plc'>TEAM</a> <font color='red'>-8.3%</font>)<a href=\"https://seekingalpha.com/news/3506705-atlassian-minus-2_3-percent-beats-code-barrel-acquisition\" target=\"_blank\"> earnings report</a> beat estimates but guided a mostly in-line FY performance.</li><li>Movers include Slack (<a href='https://seekingalpha.com/symbol/WORK' title='Slack Technologies, Inc.'>WORK</a> <font color='red'>-9.7%</font>), Alteryx (<a href='https://seekingalpha.com/symbol/AYX' title='Alteryx, Inc.'>AYX</a> <font color='red'>-6.1%</font>), Coupa Software (<a href='https://seekingalpha.com/symbol/COUP' title='Coupa Software Incorporated'>COUP</a> <font color='red'>-6.4%</font>), and MongoDB (<a href='https://seekingalpha.com/symbol/MDB' title='MongoDB, Inc.'>MDB</a> <font color='red'>-6.4%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3506970\" data-linked=\"Atlassian print leads software stocks lower\" data-tweet=\"$TEAM $WORK $AYX - Atlassian print leads software stocks lower https://seekingalpha.com/news/3506970-atlassian-print-leads-software-stocks-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3506970-atlassian-print-leads-software-stocks-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506963\" data-ts=\"1571411823\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SXT\" target=\"_blank\">SXT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506963-sensient-technologies-down-9-post-q3-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sensient Technologies down 9% post Q3 earnings miss</a></h4><div><ul><li>Sensient Technologies (<a href='https://seekingalpha.com/symbol/SXT' title='Sensient Technologies Corporation'>SXT</a> <font color=\"red\">-9.8%</font>) reported Q2 revenue decline of 7.3% Y/Y to $317.65M. Revenue by segments: Flavors &amp; Fragrances $167.58M (-9.1% Y/Y); Color $127.01M (-6% Y/Y); and Asia Pacific $30.13M (-3.7% Y/Y).</li><li>Q3 Operating margin <font color=\"red\">declined by 245 bps </font>to 12.2%.</li><li>Q3 Adj. EBITDA was $53.09M (-15.8% Y/Y); and margin <font color=\"red\">declined by 168 bp</font>s to 16.7%.</li><li>Net cash provided by operating activities YTD was $127.58M, compared to $8.86M a year ago.</li><li><strong>FY19 Outlook:</strong> EPS $2.90 to $3.00; company expect full year local currency adjusted EBITDA to be below last year\u2019s results.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3506813-sensient-technologies-eps-misses-0_05-misses-revenue\" target=\"_blank\">Sensient Technologies EPS misses by $0.05, misses on revenue</a> (Oct. 18)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3506963\" data-linked=\"Sensient Technologies down 9% post Q3 earnings miss\" data-tweet=\"$SXT - Sensient Technologies down 9% post Q3 earnings miss https://seekingalpha.com/news/3506963-sensient-technologies-down-9-post-q3-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3506963-sensient-technologies-down-9-post-q3-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506961\" data-ts=\"1571411472\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DERM\" target=\"_blank\">DERM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506961-dermira-up-29-on-additional-mid-stage-data-on-dermatitis-med-lebrikizumab\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dermira up 29% on additional mid-stage data on dermatitis med lebrikizumab</a></h4><ul><li>Dermira (<a href='https://seekingalpha.com/symbol/DERM' title='Dermira, Inc.'>DERM</a> <font color=\"green\">+28.5%</font>) is up on a 9x surge in volume on the heels of <a href=\"https://seekingalpha.com/pr/17666759-dermira-presents-data-phase-2b-study-lebrikizumab-patients-atopic-dermatitis-fall-clinical\" target=\"_blank\">detailed results</a> from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03443024?lead=dermira&amp;phase=1&amp;rank=2\" target=\"_blank\">Phase 2 clinical trial</a> evaluating a range of doses of lebrikizumab in adolescent and adult patients with moderate-to-severe atopic dermatitis &#40;AD&#41;. The data are being presented at the Annual Fall Dermatology Conference in Las Vegas.</li><li>As <a href=\"https://seekingalpha.com/news/3443541-dermira-74-percent-premarket-positive-lebrikizumab-data\" target=\"_blank\">reported </a>in March, the 280-subject study met the primary endpoint of a statistically significant improvement in an AD scale called EASI at week 16 compared to placebo across all doses tested.</li><li>All key secondary endpoints were also met, including changes in pruritis (itchy skin) and sleep loss scores. No new safety signals were observed.</li><li>Phase 3 development is underway.</li><li>Lebrikizumab is an injectable humanized monoclonal antibody that binds to (inhibits) a pro-inflammatory protein called interleukin-13 (IL-13).</li><li>The company will host a conference call today at 4:45 pm ET to discuss the results.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506961\" data-linked=\"Dermira up 29% on additional mid-stage data on dermatitis med lebrikizumab\" data-tweet=\"$DERM - Dermira up 29% on additional mid-stage data on dermatitis med lebrikizumab https://seekingalpha.com/news/3506961-dermira-up-29-on-additional-mid-stage-data-on-dermatitis-med-lebrikizumab?source=tweet\" data-url=\"https://seekingalpha.com/news/3506961-dermira-up-29-on-additional-mid-stage-data-on-dermatitis-med-lebrikizumab\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506958\" data-ts=\"1571410972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506958-dermira-and-nuvectra-among-healthcare-gainers-mirati-therapeutics-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dermira and Nuvectra among healthcare gainers; Mirati Therapeutics leads the losers</a></h4><ul><li><b>Gainers: </b>Bionano Genomics (NASDAQ:<a href='https://seekingalpha.com/symbol/BNGO' title='Bionano Genomics, Inc.'>BNGO</a>) <font color=\"green\">+55%</font>. Dermira (NASDAQ:<a href='https://seekingalpha.com/symbol/DERM' title='Dermira, Inc.'>DERM</a>) <font color=\"green\">+30%</font>. Nuvectra (NASDAQ:<a href='https://seekingalpha.com/symbol/NVTR' title='Nuvectra Corporation'>NVTR</a>) <font color=\"green\">+29%</font>. Menlo Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MNLO' title='Menlo Therapeutics Inc.'>MNLO</a>) <font color=\"green\">+15%</font>. Check-Cap (NASDAQ:<a href='https://seekingalpha.com/symbol/CHEK' title='Check-Cap Ltd.'>CHEK</a>) <font color=\"green\">+13%</font>.</li><li><b>Losers: </b>Mirati Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MRTX' title='Mirati Therapeutics, Inc.'>MRTX</a>) <font color=\"red\">-11%</font>. Hepion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/HEPA' title='Hepion Pharmaceuticals, Inc.'>HEPA</a>) <font color=\"red\">-10%</font>. Can-Fite BioPharma (NYSEMKT:<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite BioPharma Ltd.'>CANF</a>) <font color=\"red\">-9%</font>. BIOLASE (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOL' title='BIOLASE, Inc.'>BIOL</a>) <font color=\"red\">-9%</font>. Tyme Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506958\" data-linked=\"Dermira and Nuvectra among healthcare gainers; Mirati Therapeutics leads the losers\" data-tweet=\"$BNGO $DERM $NVTR - Dermira and Nuvectra among healthcare gainers; Mirati Therapeutics leads the losers https://seekingalpha.com/news/3506958-dermira-and-nuvectra-among-healthcare-gainers-mirati-therapeutics-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3506958-dermira-and-nuvectra-among-healthcare-gainers-mirati-therapeutics-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506957\" data-ts=\"1571410334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WEYL\" target=\"_blank\">WEYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506957-weyland-tech-expects-positive-adjusted-ebitda-for-q3-sharesplus-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weyland Tech expects positive adjusted EBITDA for Q3; shares +12%</a></h4><ul><li>Weyland Tech (<a href='https://seekingalpha.com/symbol/WEYL' title='Weyland Tech Inc.'>OTCQX:WEYL</a> <font color='green'>+12.8%</font>) <a href=\"https://seekingalpha.com/pr/17667278-weyland-tech-reports-preliminary-results-first-nine-months-2019-expects-revenue-42_6-percent\" target=\"_blank\">expects</a> Q3 revenue of ~$9.0M (+6.6% Y/Y). WEYL expects record revenue of ~$24.6M (first 9 months) (+42.6% Y/Y).</li><li>In addition, The company also expects to turn adjusted EBITDA positive in the Q3.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506957\" data-linked=\"Weyland Tech expects positive adjusted EBITDA for Q3; shares +12%\" data-tweet=\"$WEYL - Weyland Tech expects positive adjusted EBITDA for Q3; shares +12% https://seekingalpha.com/news/3506957-weyland-tech-expects-positive-adjusted-ebitda-for-q3-sharesplus-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3506957-weyland-tech-expects-positive-adjusted-ebitda-for-q3-sharesplus-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506956\" data-ts=\"1571410245\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLT\" target=\"_blank\">TLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506956-feds-george-keeps-hawkish-stance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fed&#39;s George keeps her hawkish stance</a></h4><ul><li>Kansas City Fed President Esther George, who voted against the last two Fed rate cuts, isn't changing her stance.</li><li>\"My own outlook for the economy does not call for a monetary policy response,\" <a href=\"https://www.kansascityfed.org/~/media/files/publicat/speeches/2019/2019-george-denver-10-18.pdf\" target=\"_blank\">she said at a speech </a>in Denver today.</li><li>Translation: No monetary response means keep rates where they are.</li><li>Even with the recent weakness in manufacturing and business investment, monetary policy may not be the appropriate tool to offset the risks faced by businesses \"when weighted against the costs that could be associated with such action,\" she added.</li><li>But she'll keep an eye on risks. \"Should downside risks spill over into the broader economy in a way that fundamentally affects the consumer and shifts the overall outlook, a monetary policy response may be required,\" she concluded.</li><li>Markets have priced in a 25-basis-point rate cut for the FOMC meeting later this month; the <a href=\"https://www.cmegroup.com/trading/interest-rates/countdown-to-fomc.html\" target=\"_blank\">CME FedWatch Tool</a> puts the probability of a rate cut at 89%, up from 67% a week ago.</li><li>10-year Treasury yield is down a basis point at 1.743%.</li><li>iShares 20+ Year Treasury Bond ETF (<a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a> <font color='green'>+0.2%</font>); ProShares UltraShort 20+ Year Treasury ETF (<a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a> <font color='red'>-0.5%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3506956\" data-linked=\"Fed&#39;s George keeps her hawkish stance\" data-tweet=\"$TLT $TBT - Fed&#39;s George keeps her hawkish stance https://seekingalpha.com/news/3506956-feds-george-keeps-hawkish-stance?source=tweet\" data-url=\"https://seekingalpha.com/news/3506956-feds-george-keeps-hawkish-stance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506955\" data-ts=\"1571410210\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CJREF\" target=\"_blank\">CJREF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506955-corusminus-11_8-after-flat-q4-lower-profits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corus -11.8% after flat Q4 with lower profits</a></h4><ul>    <li>Corus Entertainment (<a href='https://seekingalpha.com/symbol/CJREF' title='Corus Entertainment Inc.'>OTCPK:CJREF</a>) is <font color=\"red\">11.8% lower</font> after <a href=\"https://seekingalpha.com/news/3506800-corus-entertainment-eps-beats-c-0_01-revenue-line\" target=\"_blank\">fiscal Q4 results</a> with flat revenues despite some solid cash generation.</li>    <li>Television advertising grew, but revenues overall dropped fractionally to C$377.5M.</li>    <li>Attributable adjusted net income fell to C$27.9M from C$39.5M (the prior-year quarter was adjusted for the impact of acquisition, integration and restructuring costs of C$7.7M).</li>    <li>Consolidated segment profit was down 4% to C$109.8M.</li>    <li>Revenue breakout: Television, C$343.76M (down 0.3%); Radio, C$33.7M (down 2.1%).</li>   <li>Profit by segment: Television, C$108.6M (down 0.1%); Radio, C$6.9M (down 18.3%).</li>    <li>Free cash flow was C$93.6M, down 2.5%.</li>     <li><a href=\"https://seekingalpha.com/article/4297254-corus-entertainment-inc-2019-q4-results-earnings-call-presentation\" target=\"_blank\">Earnings call slides</a></li>   <li><a href=\"https://seekingalpha.com/pr/17667100-corus-entertainment-announces-fiscal-2019-fourth-quarter-year-end-results\" target=\"_blank\">Press release</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3506955\" data-linked=\"Corus -11.8% after flat Q4 with lower profits\" data-tweet=\"$CJREF - Corus -11.8% after flat Q4 with lower profits https://seekingalpha.com/news/3506955-corusminus-11_8-after-flat-q4-lower-profits?source=tweet\" data-url=\"https://seekingalpha.com/news/3506955-corusminus-11_8-after-flat-q4-lower-profits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506951\" data-ts=\"1571409226\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506951-marten-transportplus-4_2-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marten Transport +4.2% post Q3 results</a></h4><ul><li>Marten Transport (<a href='https://seekingalpha.com/symbol/MRTN' title='Marten Transport, Ltd.'>MRTN</a> <font color=\"green\">+4.2%</font>) reports <a href=\"https://seekingalpha.com/pr/17666725-marten-transport-announces-third-quarter-results\" target=\"_blank\">Q3</a> revenue growth of 7.7% Y/Y to 214.9M.</li><li>Segment revenue: Truckload $94.99M (+1.1% Y/Y); Dedicated $70.3M (+19.6% Y/Y); Intermodal $22.3M (-14% Y/Y) &amp; Brokerage of $27.4M (+30.3% Y/Y).</li><li>Operating margin: Total operating <font color=\"green\">increased 20 bps</font> to 90.7%; Truckload <font color=\"green\">increased 340 bps</font> to 92.7%; Dedicated <font color=\"red\">declined 520 bps</font> to 85.9%; Intermodal <font color=\"green\">increased 430 bps</font> to 94.6% &amp; Brokerage <font color=\"red\">declined 130 bps</font> to 92.9%.</li><li>Fuel surcharge revenue decreased to $26.1M, from $27.9M same quarter last year.</li><li>Average revenue, net of fuel surcharges, per tractor per week: Truckload $3,723M; Dedicated $3,392M.</li><li>Average tractors: Truckload 1,695; Dedicated 1,329 &amp; Intermodal 87.</li><li>Average miles per trip: Truckload 545; Dedicated 312.</li><li>Net cash provided by operating activities for the quarter was $46.1M, compared to $44.72M a year ago.</li><li>\u201cWe expect to continue expanding our capacity to service our customers by offering the best jobs for the industry\u2019s best drivers.\u201d said Randolph L. Marten, Chairman and CEO.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3506670-marten-transport-eps-beats-0_02-beats-revenue\" target=\"_blank\">Marten Transport EPS beats by $0.02, beats on revenue</a> (Oct. 17 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3506951\" data-linked=\"Marten Transport +4.2% post Q3 results\" data-tweet=\"$MRTN - Marten Transport +4.2% post Q3 results https://seekingalpha.com/news/3506951-marten-transportplus-4_2-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3506951-marten-transportplus-4_2-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506950\" data-ts=\"1571408698\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TYME\" target=\"_blank\">TYME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506950-tyme-tech-down-8-on-30m-stock-sales-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyme Tech down 8% on $30M stock sales deal</a></h4><ul><li>Tyme Technologies (<a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a> <font color=\"red\">-8.2%</font>) inks an <a href=\"https://www.sec.gov/Archives/edgar/data/1537917/000119312519269792/d814527d8k.htm\" target=\"_blank\">agreement </a>with Jefferies LLC for the at-the-market sale of up to $30M of its common stock. Jefferies will earn a 3% commission for its efforts.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506950\" data-linked=\"Tyme Tech down 8% on $30M stock sales deal\" data-tweet=\"$TYME - Tyme Tech down 8% on $30M stock sales deal https://seekingalpha.com/news/3506950-tyme-tech-down-8-on-30m-stock-sales-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3506950-tyme-tech-down-8-on-30m-stock-sales-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506946\" data-ts=\"1571408119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUN\" target=\"_blank\">HUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506946-huntsman-added-to-jefferies-franchise-picks-list\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Huntsman added to Jefferies Franchise Picks List</a></h4><ul><li>Huntsman (<a href='https://seekingalpha.com/symbol/HUN' title='Huntsman Corporation'>HUN</a> <font color='green'>+2.1%</font>) heads higher after Jefferies <a href=\"https://thefly.com/thestreet/realmoney/index.php/HUNid2977417/HUN-Huntsman-added-to-Franchise-Picks-List-at-Jefferies\" target=\"_blank\">adds the stock to the Franchise Picks List</a> with a Buy rating and $28 price target, citing one of the strongest balance sheets in  the chemicals space, a less cyclical mix but still significant operating leverage and  innovation that should allow for growth ahead of GDP.</li><li>HUN \"should be one of the first and fastest out of the gate\" if leading indicators continue to turn and investors continue to embrace at least a modest  cyclical reflation, says Jefferies analyst Laurence Alexander.</li><li>HUN has a  path to $40-plus per share \"in a sustained cyclical rally\" and more than $60  \"at the peak of a synchronized global up-cycle,\" Alexander says.</li><li>HUN's average <a href=\"https://seekingalpha.com/symbol/HUN/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> and <a href=\"https://seekingalpha.com/symbol/HUN/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors Rating</a> are Bullish/Outperform.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506946\" data-linked=\"Huntsman added to Jefferies Franchise Picks List\" data-tweet=\"$HUN - Huntsman added to Jefferies Franchise Picks List https://seekingalpha.com/news/3506946-huntsman-added-to-jefferies-franchise-picks-list?source=tweet\" data-url=\"https://seekingalpha.com/news/3506946-huntsman-added-to-jefferies-franchise-picks-list\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506934\" data-ts=\"1571406758\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506934-exponent-slides-7_4-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exponent slides 7.4% post Q3 results</a></h4><ul><li>Exponent (<a href='https://seekingalpha.com/symbol/EXPO' title='Exponent, Inc.'>EXPO</a> <font color=\"red\">-7.4%</font>) reports <a href=\"https://seekingalpha.com/pr/17666765-exponent-reports-third-quarter-fiscal-year-2019-financial-results\" target=\"_blank\">Q3</a> revenue growth of 6.6% Y/Y to $101.55M.</li><li>Revenues before reimbursements were $95.5M (+8% Y/Y) &amp; Reimbursements of $6M (-8.3% Y/Y).</li><li>Operating margin <font color=\"green\">increased 124 bps</font> to 22.9% &amp; EBITDA margin <font color=\"red\">declined 40 bps</font> to 25.6%.</li><li>In a separate press release today, the company announced a $0.16 quarterly dividend.</li><li>Year to date, Exponent distributed $25.2M in dividends and closed the period with $210M in cash, equivalents and short-term investments.</li><li><b>Outlook 2019:</b> Expect revenues before reimbursements to grow in the high-single digits Y/Y and EBITDA<sup> </sup>margin to be down ~25 bps.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3506673-exponent-declares-0_16-dividend\" target=\"_blank\">Exponent declares $0.16 dividend</a> (Oct. 17 2019)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3506679-exponent-eps-beats-0_02-beats-revenue\" target=\"_blank\">Exponent EPS beats by $0.02, beats on revenue</a> (Oct. 17 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3506934\" data-linked=\"Exponent slides 7.4% post Q3 results\" data-tweet=\"$EXPO - Exponent slides 7.4% post Q3 results https://seekingalpha.com/news/3506934-exponent-slides-7_4-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3506934-exponent-slides-7_4-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506919\" data-ts=\"1571405281\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QTNT\" target=\"_blank\">QTNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506919-quotient-up-11-premarket-on-positive-ih-microarray-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quotient up 11% premarket on positive IH Microarray data</a></h4><ul><li>Thinly traded Quotient (NASDAQ:<a href='https://seekingalpha.com/symbol/QTNT' title='Quotient Limited'>QTNT</a>) is up <font color=\"green\">11%</font> premarket on light volume in reaction to <a href=\"https://seekingalpha.com/pr/17666905-quotient-announces-positive-verification-validation-results-extended-immunohematology\" target=\"_blank\">positive Verification &amp; Validation data</a> on its Extended Immunohematology &#40;IH&#41; Microarray.</li><li>The concordance rates across a range of antigen types were 97.7 - 100.0%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506919\" data-linked=\"Quotient up 11% premarket on positive IH Microarray data\" data-tweet=\"$QTNT - Quotient up 11% premarket on positive IH Microarray data https://seekingalpha.com/news/3506919-quotient-up-11-premarket-on-positive-ih-microarray-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3506919-quotient-up-11-premarket-on-positive-ih-microarray-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506914\" data-ts=\"1571404955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506914-micronminus-1_4-after-weak-dram-pricing-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron -1.4% after weak DRAM pricing data</a></h4><ul><li>Memory market research firm <a href=\"http://www.insye.com/\" target=\"_blank\">inSpectrum Tech</a>'s weekly report shows DRAM chip spot prices falling 2% in the latest week, larger than the 1.5% average decline over the previous six weeks.</li><li>Last week's report showed a 0.8% decline.</li><li>Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology, Inc.'>MU</a>) shares are <font color=\"red\">down 1.4%</font> pre-market after the report.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506914\" data-linked=\"Micron -1.4% after weak DRAM pricing data\" data-tweet=\"$MU - Micron -1.4% after weak DRAM pricing data https://seekingalpha.com/news/3506914-micronminus-1_4-after-weak-dram-pricing-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3506914-micronminus-1_4-after-weak-dram-pricing-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>98&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506907\" data-ts=\"1571404656\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NNA\" target=\"_blank\">NNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506907-navios-maritime-acquisitionminus-13-after-pricing-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Navios Maritime Acquisition -13% after pricing offering</a></h4><ul> <li>Navios Maritime Acquisition (NYSE:<a href='https://seekingalpha.com/symbol/NNA' title='Navios Maritime Acquisition Corporation'>NNA</a>) prices an offering of 1,875,000 shares at $8.00 per share.</li><li>The offering is expected to close on or about October 24.</li><li>The company expects proceeds will be approximately $14M after expenses. Navios anticipates using the proceeds from the registered direct offering for general corporate purposes.</li><li>NNA  <font color=\"red\">-12.55%</font> premarket to  $9.13.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17667387-navios-maritime-acquisition-corporation-announces-15-million-offering-common-stock\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3506907\" data-linked=\"Navios Maritime Acquisition -13% after pricing offering\" data-tweet=\"$NNA - Navios Maritime Acquisition -13% after pricing offering https://seekingalpha.com/news/3506907-navios-maritime-acquisitionminus-13-after-pricing-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3506907-navios-maritime-acquisitionminus-13-after-pricing-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>139&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506906\" data-ts=\"1571404627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAT\" target=\"_blank\">CAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506906-caterpillar-cut-morgan-stanley-on-weakness-in-two-biggest-segments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caterpillar cut at Morgan Stanley on weakness in two biggest segments</a></h4><ul><li>Caterpillar (NYSE:<a href='https://seekingalpha.com/symbol/CAT' title='Caterpillar Inc.'>CAT</a>) <font color=\"red\">-1.8%</font> pre-market after Morgan Stanley <a href=\"https://thefly.com/thestreet/realmoney/index.php/CATid2977361/CAT-Morgan-Stanley-downgrades-Caterpillar-sees--declines-for-two-biggest-units\" target=\"_blank\">downgraded</a> shares to Equal Weight from Overweight with a $145 price target, trimmed from $150, citing increasing downside risks to the company's Construction and Energy and Transportation segments.</li><li>Stanley analyst Courtney Yakavonis says CAT's U.S. Construction Equipment market peaked in 2019 and that its Energy and Transportation markets will fail to re-accelerate in 2020, prompting her to forecast negative growth in the company's two largest business segments in 2020.</li><li>CAT's Resources segment and share repurchases continue to support earnings but are unable to fully offset the other headwinds, Yakavonis says, as her updated CAT estimates now call for a mild Y/Y earnings decline in 2020.</li><li>CAT's average <a href=\"https://seekingalpha.com/symbol/CAT/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> and <a href=\"https://seekingalpha.com/symbol/CAT/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors Rating</a> are Neutral/Hold.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506906\" data-linked=\"Caterpillar cut at Morgan Stanley on weakness in two biggest segments\" data-tweet=\"$CAT - Caterpillar cut at Morgan Stanley on weakness in two biggest segments https://seekingalpha.com/news/3506906-caterpillar-cut-morgan-stanley-on-weakness-in-two-biggest-segments?source=tweet\" data-url=\"https://seekingalpha.com/news/3506906-caterpillar-cut-morgan-stanley-on-weakness-in-two-biggest-segments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506902\" data-ts=\"1571404216\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506902-gil-gps-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GIL, GPS among premarket losers</a></h4><ul><li>Gildan Activewear (NYSE:<a href='https://seekingalpha.com/symbol/GIL' title='Gildan Activewear Inc.'>GIL</a>) <font color=\"red\">-34%</font> on Q3 <a href=\"https://seekingalpha.com/news/3506763-gildan-minus-12_5-percent-preliminary-results-guidance-cut\" target=\"_blank\">preliminary results</a>.</li><li>Hepion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/HEPA' title='Hepion Pharmaceuticals, Inc.'>HEPA</a>) <font color=\"red\">-8%</font>.</li><li>L Brands (NYSE:<a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a>) <font color=\"red\">-7%</font>.</li><li>The Gap (NYSE:<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a>) <font color=\"red\">-6%</font>.</li><li>Ocugen (NASDAQ:<a href='https://seekingalpha.com/symbol/OCGN' title='Ocugen, Inc.'>OCGN</a>) <font color=\"red\">-5%</font>.</li><li>Coca-Cola FEMSA, S.A.B. de C.V. (NYSE:<a href='https://seekingalpha.com/symbol/KOF' title='Coca-Cola FEMSA, S.A.B. de C.V.'>KOF</a>) <font color=\"red\">-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506902\" data-linked=\"GIL, GPS among premarket losers\" data-tweet=\"$GIL $HEPA $LB - GIL, GPS among premarket losers https://seekingalpha.com/news/3506902-gil-gps-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3506902-gil-gps-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506901\" data-ts=\"1571404142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506901-mnk-dvax-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MNK, DVAX among premarket gainers</a></h4><ul><li>Attis Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/ATIS' title='Attis Industries, Inc.'>ATIS</a>) <font color=\"green\">+57%</font>.</li><li>Bionano Genomics (NASDAQ:<a href='https://seekingalpha.com/symbol/BNGO' title='Bionano Genomics, Inc.'>BNGO</a>) <font color=\"green\">+32%</font>.</li><li>ClearSign Combustion (NASDAQ:<a href='https://seekingalpha.com/symbol/CLIR' title='ClearSign Combustion Corporation'>CLIR</a>) <font color=\"green\">+25%</font> on engineering <a href=\"https://seekingalpha.com/pr/17667261-clearsign-combustion-corporation-receives-engineering-order-exxon-mobil-corporation\" target=\"_blank\">order</a> from Exxon Mobil.</li><li>Nuvectra (NASDAQ:<a href='https://seekingalpha.com/symbol/NVTR' title='Nuvectra Corporation'>NVTR</a>) <font color=\"green\">+17%</font> on <a href=\"https://seekingalpha.com/pr/17667225-nuvectra-submits-chemical-composition-biocompatibility-data-fda-virtis\" target=\"_blank\">chemical composition</a> and biocompatibility data to FDA for Virtis.</li><li>Mallinckrodt plc (NYSE:<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt plc'>MNK</a>) <font color=\"green\">+6%</font>.</li><li>Endo International plc (NASDAQ:<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a>) <font color=\"green\">+6%</font>.</li><li>Dynavax Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/DVAX' title='Dynavax Technologies Corporation'>DVAX</a>) <font color=\"green\">+6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506901\" data-linked=\"MNK, DVAX among premarket gainers\" data-tweet=\"$ATIS $BNGO $CLIR - MNK, DVAX among premarket gainers https://seekingalpha.com/news/3506901-mnk-dvax-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3506901-mnk-dvax-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506895\" data-ts=\"1571403809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506895-q4-will-change-snaps-narrative-bofa\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Q4 will change Snap&#39;s narrative - BofA</a></h4><ul><li>Bank of America upgrades Snap (NYSE:<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>) from Neutral to Buy on higher conviction of potential ARPU expansion, driven by the ongoing Discover content rollout.</li><li>BofA also notes solid industry ad spend checks and expects Q4 to be Snap's first EBITDA positive quarter, which would change the narrative.</li><li>Snap will report Q3 results on October 22.</li><li>SNAP is <font color=\"green\">up 2.8%</font> pre-market to $14.17. The company has a Hold average <a href=\"https://seekingalpha.com/symbol/SNAP/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506895\" data-linked=\"Q4 will change Snap&#39;s narrative - BofA\" data-tweet=\"$SNAP - Q4 will change Snap&#39;s narrative - BofA https://seekingalpha.com/news/3506895-q4-will-change-snaps-narrative-bofa?source=tweet\" data-url=\"https://seekingalpha.com/news/3506895-q4-will-change-snaps-narrative-bofa\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506888\" data-ts=\"1571403463\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506888-j-and-j-recalls-lot-of-baby-powder-on-trace-levels-of-asbestos\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J&amp;J recalls lot of Baby Powder on trace levels of asbestos</a></h4><ul><li>Johnson &amp; Johnson (NYSE:<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a>) initiates a <a href=\"https://seekingalpha.com/pr/17667296-johnson-and-johnson-consumer-inc-voluntarily-recall-single-lot-johnsons-baby-powder-united\" target=\"_blank\">voluntary recall</a> of a single lot of its Baby Powder after an FDA test showed sub-trace levels of chrysotile asbestos (less than or equal to 0.00002%) in samples from a single bottle purchased from an online retailer.</li><li>The company says it has launched a \"rigorous\" investigation into the matter and is working with the agency to determine the integrity of the sample and the validity of the test results.</li><li>Shares down <font color=\"red\">2%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506888\" data-linked=\"J&amp;J recalls lot of Baby Powder on trace levels of asbestos\" data-tweet=\"$JNJ - J&amp;J recalls lot of Baby Powder on trace levels of asbestos https://seekingalpha.com/news/3506888-j-and-j-recalls-lot-of-baby-powder-on-trace-levels-of-asbestos?source=tweet\" data-url=\"https://seekingalpha.com/news/3506888-j-and-j-recalls-lot-of-baby-powder-on-trace-levels-of-asbestos\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>207&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506885\" data-ts=\"1571403063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNLO\" target=\"_blank\">MNLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506885-mizuho-likes-unitedhealth-group-after-q3-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mizuho likes UnitedHealth Group after Q3 beat</a></h4><ul><li>Menlo Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MNLO' title='Menlo Therapeutics Inc.'>MNLO</a>) initiated with Buy rating and $11 (140% upside) price target at H.C. Wainwright.</li><li>Dynavax Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/DVAX' title='Dynavax Technologies Corporation'>DVAX</a>) initiated with Buy rating and $13 (207% upside) price target at Wainwright. Shares up <font color=\"green\">6% </font>premarket.</li><li>UnitedHealth Group (NYSE:<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Incorporated'>UNH</a>) initiated with Buy rating and $270 (11% upside) price target at Mizuho Securities. Shares up <font color=\"green\">1% </font>after hours.</li><li>Humana (NYSE:<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a>) initiated with Buy rating and $316 (11% upside) price target at Mizuho.</li><li>Anthem (NYSE:<a href='https://seekingalpha.com/symbol/ANTM' title='Anthem, Inc.'>ANTM</a>) initiated with Neutral rating and $262 (5% upside) price target at Mizuho.</li><li>Tandem Diabetes Care (NASDAQ:<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a>) initiated with Buy rating and $76 (21% upside) price target at Guggenheim. Shares up <font color=\"green\">2%</font> premarket.</li><li>Cardiovascular Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CSII' title='Cardiovascular Systems, Inc.'>CSII</a>) initiated with Buy rating and $58 (22% upside) price target at Guggenheim.</li><li>Fluidigm (NASDAQ:<a href='https://seekingalpha.com/symbol/FLDM' title='Fluidigm Corporation'>FLDM</a>) upgraded to Buy with a $7 (62% upside) price target at UBS citing an attractive entry point considering its revenue growth outlook. Shares up <font color=\"green\">13%</font> premarket.</li><li>Charles River Laboratories (NYSE:<a href='https://seekingalpha.com/symbol/CRL' title='Charles River Laboratories International, Inc.'>CRL</a>) downgraded to Neutral with a $150 (10% upside) price target at BofA Merrill Lynch.</li><li>Insulet (NASDAQ:<a href='https://seekingalpha.com/symbol/PODD' title='Insulet Corporation'>PODD</a>) downgraded to Hold with a $145 (7% downside risk) price target at Canaccord Genuity citing valuation.</li><li>Agilent (NYSE:<a href='https://seekingalpha.com/symbol/A' title='Agilent Technologies, Inc.'>A</a>) downgraded to Neutral with an $82 (9% upside) price target. Shares down <font color=\"red\">2%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506885\" data-linked=\"Mizuho likes UnitedHealth Group after Q3 beat\" data-tweet=\"$MNLO $DVAX $UNH - Mizuho likes UnitedHealth Group after Q3 beat https://seekingalpha.com/news/3506885-mizuho-likes-unitedhealth-group-after-q3-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3506885-mizuho-likes-unitedhealth-group-after-q3-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506871\" data-ts=\"1571401668\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETFC\" target=\"_blank\">ETFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506871-wolfe-research-boosts-e-trade-eps-estimates-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wolfe Research boosts E*Trade EPS estimates, price target</a></h4><ul><li>Wolfe Research analyst Steven Chubak expects E*Trade Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/ETFC' title='E*TRADE Financial Corporation'>ETFC</a>) shares to rally even though questions surrounding potential for M&amp;A/strategic alternatives overshadowed positive trends highlighted in Q3 results in the earnings call.</li><li>ETFC <font color=\"green\">rises 3.6%</font> in premarket trading.</li><li>Chubak, with an outperform rating on E*Trade, sees higher cash balances and more aggressive expense initiatives driving consensus higher and supporting a higher standalone valuation.</li><li>ETFC trimmed its 2023 EPS target to $6 from $7, but sees a path to $7 by 2024.</li><li>Chubak raises ETFC 2020 estimate to $3.36 from $3.06 (compares with consensus of $3.35) and 2021 estimate to $3.38 from $2.95 (compares with $3.43 consensus); boosts price target to $46 from $43.</li><li>Chubak's outperform rating on ETFC contrasts with Quant rating of<a href=\"https://seekingalpha.com/symbol/ETFC/ratings/quant-ratings\" target=\"_blank\"> Bearish</a>; agrees with the Sell-Side average rating of <a href=\"https://seekingalpha.com/symbol/ETFC/ratings/sell-side-ratings\" target=\"_blank\">Outperform </a>(5 Buy, 6 Outperform, 6 Hold, 1 Underperform).</li></ul><div class=\"tiny-share-widget\" data-id=\"3506871\" data-linked=\"Wolfe Research boosts E*Trade EPS estimates, price target\" data-tweet=\"$ETFC - Wolfe Research boosts E*Trade EPS estimates, price target https://seekingalpha.com/news/3506871-wolfe-research-boosts-e-trade-eps-estimates-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3506871-wolfe-research-boosts-e-trade-eps-estimates-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506862\" data-ts=\"1571400873\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNTX\" target=\"_blank\">GNTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506862-gentex-narrowed-fy2019-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gentex narrowed its FY2019 outlook</a></h4><ul><li>Gentex (NASDAQ:<a href='https://seekingalpha.com/symbol/GNTX' title='Gentex Corporation'>GNTX</a>) reports Automotive net sales rose 3.4% to $464.3M in <a href=\"https://seekingalpha.com/pr/17667211-gentex-reports-third-quarter-2019-financial-results\" sasource=\"qp_sum_news_9\" target=\"_blank\">Q3</a>, driven primarily by strength in Full Display Mirror shipments, as well as an 18% increase in exterior auto-dimming mirror unit shipments.</li><li>Total auto-dimming mirror shipment units +6% Y/Y to 10,841.</li><li>Gross margin rate up 10 bps to 37.7%.</li><li>Operating margin rate decreased 90 bps to 26.8%.</li><li>The company repurchased 3.6M shares during the quarter at an average price of $27.07 per share, for a total of $96.6M.</li><li><strong>Q4 Guidance</strong>: Net sales: $430M to $455M; Gross margin rate: 35% to 36%.</li><li><b>FY2019 Guidance</b>: Net sales: $1.84B to $1.87B; Gross margin rate: 36.6% to 37%; Operating expense: $198M to $200M; Tax rate: 16% to 16.5%; Capex: $90M to $100M; D&amp;A: $104M to $107M.</li><li>GNTX <font color=\"green\">+1.49%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3506857-gentex-eps-beats-0_02-beats-revenue\" target=\"_blank\">Gentex EPS beats by $0.02, beats on revenue</a> (Oct. 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3506862\" data-linked=\"Gentex narrowed its FY2019 outlook\" data-tweet=\"$GNTX - Gentex narrowed its FY2019 outlook https://seekingalpha.com/news/3506862-gentex-narrowed-fy2019-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3506862-gentex-narrowed-fy2019-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506861\" data-ts=\"1571400409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STT\" target=\"_blank\">STT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506861-state-street-q3-beats-on-strong-sequential-nii-growth-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">State Street Q3 beats on strong sequential NII growth (updated)</a></h4><ul><li>State Street (NYSE:<a href='https://seekingalpha.com/symbol/STT' title='State Street Corporation'>STT</a>) <font color=\"green\">jumps 3.9% </font>in premarket trading after <a href=\"https://seekingalpha.com/pr/17667163-state-street-reports-third-quarter-2019-eps-1_42-per-share-1_51-per-share-excluding-notable\" target=\"_blank\">Q3 adjusted EPS </a>of $1.51 blows past the average analyst estimate of $1.40</li><li>\"Despite an uncertain revenue environment, we saw sequential fee revenue growth in FX trading services in our Global Markets business and strong NII,\" said President and CEO Ron O'Hanley.</li><li>Q3 net interest income of $644M rose 5.1% Q/Q, fell 4.2% Y/Y; net interest margin on FTE basis of 1.42% increased from 1.38% in Q2 and fell from 1.48% in the year-ago quarter.</li><li>Q3 total fee revenue of $2.26B was flat vs. Q2 and fell 2.5% Y/Y.</li><li>Q3 pretax margin of 24.8% vs. 25.0% in Q2 and 29.9% in Q3 2018.</li><li>\"While our pre-tax margin and return on equity fell short of medium-term targets, we remain committed to our 2019 expense program and the expected realization of $400M in savings by year end,\" O'Hanley said.</li><li>Investment Servicing mandates announced in Q3 totaled $1.0% with quarter-end servicing assets remaining to be installed in future periods of $1.2T.</li><li>Investment Management net inflows of $13B in Q3, driven by cash and ETF inflows.</li><li>Q3 assets under custody/administration of $32.9T, up 0.4% Q/Q and down 3.2% Y/Y.</li><li>Q3 assets under management of $2.95T, up 1.2% Q/Q and up 5.1% Y/Y.</li><li>Q3 return on average common equity of 9.7% slipped from 10.1% in Q2 and 14.0% in Q3 2018.</li><li><strong>Q4 outlook</strong>: <a href=\"http://investors.statestreet.com/Cache/1500124410.PDF?O=PDF&amp;T=&amp;Y=&amp;D=&amp;FID=1500124410&amp;iid=100447\" target=\"_blank\">Sees fee revenue </a>up 1%-2% sequentially, driven by CRD seasonality.</li><li>Sees Q4 NII down 3%-5% Q/Q, adjusting for Q3 2019 episodic market-related benefits, driven by lower long-end rates.</li><li>Sees expenses excluding notable items roughly flat vs. Q3.</li><li><a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Finvestors.statestreet.com%2F&amp;esheet=52113414&amp;newsitemid=20191018005203&amp;lan=en-US&amp;anchor=http%3A%2F%2Finvestors.statestreet.com%2F&amp;index=1&amp;md5=7eb3b18e04b3445e2b3a974673855d65\" target=\"_blank\">Conference call</a> at 10:00 AM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3506839-state-street-eps-beats-0_11-beats-revenue\" target=\"_blank\">State Street EPS beats by $0.11, beats on revenue</a> (Oct. 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3506861\" data-linked=\"State Street Q3 beats on strong sequential NII growth (updated)\" data-tweet=\"$STT - State Street Q3 beats on strong sequential NII growth (updated) https://seekingalpha.com/news/3506861-state-street-q3-beats-on-strong-sequential-nii-growth-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3506861-state-street-q3-beats-on-strong-sequential-nii-growth-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506859\" data-ts=\"1571400324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGY\" target=\"_blank\">EGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506859-vaalco-confirms-oil-discovery-gabon-appraisal-well\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vaalco confirms oil discovery at Gabon appraisal well</a></h4><ul><li>Vaalco Energy (NYSE:<a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a>) <font color=\"green\">+8.5%</font> pre-market after saying it  <a href=\"https://seekingalpha.com/pr/17666903-vaalco-energy-inc-confirms-oil-discovery-etame-9p-appraisal-wellbore\" target=\"_blank\">encountered oil sands</a> at its Etame appraisal well located offshore Gabon.</li><li>EGY says the first well of its three-well campaign offshore Gabon was successfully drilled to a total depth of 10,260 ft. and encountered both Gamba and Dentale oil sands.</li><li>EGY estimates gross recoverable oil resources of 2.5M-10.5M barrels of oil present in subcropping Dentale reservoirs.</li><li>The company also says the well identified an oil column which was thicker than expected in the Gamba  reservoir, which may result in higher ultimate oil recovery from the  two planned appraisal wells than previously expected.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506859\" data-linked=\"Vaalco confirms oil discovery at Gabon appraisal well\" data-tweet=\"$EGY - Vaalco confirms oil discovery at Gabon appraisal well https://seekingalpha.com/news/3506859-vaalco-confirms-oil-discovery-gabon-appraisal-well?source=tweet\" data-url=\"https://seekingalpha.com/news/3506859-vaalco-confirms-oil-discovery-gabon-appraisal-well\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506857\" data-ts=\"1571400098\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNTX\" target=\"_blank\">GNTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506857-gentex-eps-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gentex EPS beats by $0.02, beats on revenue</a></h4><ul><li>Gentex (NASDAQ:<a href='https://seekingalpha.com/symbol/GNTX' title='Gentex Corporation'>GNTX</a>): Q3 GAAP EPS of $0.44 <font color=\"green\">beats by $0.02</font>.</li><li>Revenue of $477.76M (+3.8% Y/Y) <font color=\"green\">beats by $2.63M</font>.</li><li>Shares <font color=\"green\">+1.49%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17667211-gentex-reports-third-quarter-2019-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3506857\" data-linked=\"Gentex EPS beats by $0.02, beats on revenue\" data-tweet=\"$GNTX - Gentex EPS beats by $0.02, beats on revenue https://seekingalpha.com/news/3506857-gentex-eps-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3506857-gentex-eps-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506847\" data-ts=\"1571399487\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXP\" target=\"_blank\">AXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506847-american-express-q3-reflects-strong-consumer-spending\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Express Q3 reflects strong consumer spending</a></h4><ul><li>American Express (NYSE:<a href='https://seekingalpha.com/symbol/AXP' title='American Express Company'>AXP</a>) <font color=\"green\">gains 2.0%</font> in premarket trading after <a href=\"https://seekingalpha.com/pr/17667159-american-express-reports-third-quarter-earnings-per-share-2_08\" target=\"_blank\">Q3 adjusted EPS </a>of $2.08 beats the consensus estimate of $2.02 driven by strong growth in its consumer segment.</li><li>Increased from $1.88 in the year-ago quarter.</li><li>Reaffirms 2019 adjusted EPS guidance of $7.85-$8.35; consensus estimate $8.10.</li><li>Q3 net interest income of $2.20B improves from $2.07B in Q2 and $1.96B in Q3 2018.</li><li>Q3 net interest yield on average card member loans of 11.1% increased from 10.8% in Q2 and the year-ago quarter.</li><li>Q3 Global Consumer Services Group net income of $857M, up 10% Y/Y; revenue net of interest expense was $6.0B, up 11%, primarily on higher net interest income, card member spending, and card fees.</li><li>Q3 Global Commercial Services net income of $629M, up 4% Y/Y; revenue net of interest expense rose 7% Y/Y to $3.4B, reflecting higher card member spending.</li><li>Q3 Global Merchant and Network Services net income of $600M, up 3% Y/Y; revenue net of interest expense increased 5% to $1.7B, primarily reflecting increased card member spending.</li><li><a href=\"https://ir.americanexpress.com/#parentHorizontalTab4\" target=\"_blank\">Conference call </a>at 8:30 AM.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3506835-american-express-eps-beats-0_06-beats-revenue\" target=\"_blank\">American Express EPS beats by $0.06, beats on revenue</a> (Oct. 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3506847\" data-linked=\"American Express Q3 reflects strong consumer spending\" data-tweet=\"$AXP - American Express Q3 reflects strong consumer spending https://seekingalpha.com/news/3506847-american-express-q3-reflects-strong-consumer-spending?source=tweet\" data-url=\"https://seekingalpha.com/news/3506847-american-express-q3-reflects-strong-consumer-spending\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506844\" data-ts=\"1571398958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506844-european-advisory-group-backs-abbvies-upadacitinib-for-rheumatoid-arthritis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European advisory group backs AbbVie&#39;s upadacitinib for rheumatoid arthritis</a></h4><ul><li>The European Medicines Agency's advisory group CHMP has adopted a <a href=\"https://seekingalpha.com/pr/17667160-abbvie-receives-chmp-positive-opinion-upadacitinib-rinvoq-treatment-adults-moderate-severe\" target=\"_blank\">positive opinion</a> recommending approval of AbbVie's (NYSE:<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>) JAK inhibitor RINVOQ (upadacitinib), as monotherapy or with methotrexate, for the treatment of adult patients with moderate-to-severe active rheumatoid arthritis who have not responded adequately to or are intolerant of one or more disease-modifying anti-rheumatic drugs (DMARDs).</li><li>A final decision from the European Commission usually takes ~60 days.</li><li>Shares up <font color=\"green\">1%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3506844\" data-linked=\"European advisory group backs AbbVie&#39;s upadacitinib for rheumatoid arthritis\" data-tweet=\"$ABBV - European advisory group backs AbbVie&#39;s upadacitinib for rheumatoid arthritis https://seekingalpha.com/news/3506844-european-advisory-group-backs-abbvies-upadacitinib-for-rheumatoid-arthritis?source=tweet\" data-url=\"https://seekingalpha.com/news/3506844-european-advisory-group-backs-abbvies-upadacitinib-for-rheumatoid-arthritis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506842\" data-ts=\"1571398845\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAN\" target=\"_blank\">MAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506842-manpower-down-1_5-on-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Manpower down 1.5% on earnings miss</a></h4><ul><li>Manpower (NYSE:<a href='https://seekingalpha.com/symbol/MAN' title='ManpowerGroup Inc.'>MAN</a>) reports revenues were flat on a constant currency basis in <a href=\"https://seekingalpha.com/pr/17667167-manpowergroup-reports-3rd-quarter-2019-results\" target=\"_blank\">Q3</a>.</li><li>Revenue from services: Americas: $1.07B (+2.9%); Southern Europe: $2.35B (+0.9%); Northern Europe: $1.16B (-10.1%); APME: $621.9M (-12.8%); Right Management: $48.1M (+2.5%).</li><li>Gross margin rate fell 40 bps to 16%.</li><li>Operating margin rate up 10 bps to 4.1%.</li><li>The company repurchased 610K common shares for $51M.</li><li>The company expects Q4 EPS to be between $2 to $2.08.</li><li>MAN <font color=\"red\">-1.46%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3506836-manpower-eps-misses-0_02-misses-revenue\" target=\"_blank\">Manpower EPS misses by $0.02, misses on revenue</a> (Oct. 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3506842\" data-linked=\"Manpower down 1.5% on earnings miss\" data-tweet=\"$MAN - Manpower down 1.5% on earnings miss https://seekingalpha.com/news/3506842-manpower-down-1_5-on-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3506842-manpower-down-1_5-on-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506840\" data-ts=\"1571398518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MO\" target=\"_blank\">MO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506840-cronos-group-is-new-king-in-north-stifel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cronos Group is &quot;New King in the North&quot; - Stifel</a></h4><ul><li><a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">via Notable Calls</a></li><li>C$2B of cash in the bank and the resources of major backer Altria (NYSE:<a href='https://seekingalpha.com/symbol/MO' title='Altria Group, Inc.'>MO</a>) give Cronos (NASDAQ:<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group Inc.'>CRON</a>) unconstrained ability to invest in the $200B global cannabis opportunity, says the team at Stifel, upgrading CRON to Buy. The title of the note: \"Crowning a New King in the North.\"</li><li>Shares are <font color=\"green\">up 2.5%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3506840\" data-linked=\"Cronos Group is &quot;New King in the North&quot; - Stifel\" data-tweet=\"$MO $CRON - Cronos Group is &quot;New King in the North&quot; - Stifel https://seekingalpha.com/news/3506840-cronos-group-is-new-king-in-north-stifel?source=tweet\" data-url=\"https://seekingalpha.com/news/3506840-cronos-group-is-new-king-in-north-stifel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506839\" data-ts=\"1571398427\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STT\" target=\"_blank\">STT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506839-state-street-eps-beats-0_11-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">State Street EPS beats by $0.11, beats on revenue</a></h4><ul><li>State Street (NYSE:<a href='https://seekingalpha.com/symbol/STT' title='State Street Corporation'>STT</a>): Q3 Non-GAAP EPS of $1.51 <font color=\"green\">beats by $0.11</font>; GAAP EPS of $1.42 <font color=\"green\">beats by $0.06</font>.</li><li>Revenue of $2.9B (-3.0% Y/Y) <font color=\"green\">beats by $40M</font>.</li><li>Shares <font color=\"green\">+2.2%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17667163-state-street-reports-third-quarter-2019-eps-1_42-per-share-1_51-per-share-excluding-notable\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3506839\" data-linked=\"State Street EPS beats by $0.11, beats on revenue\" data-tweet=\"$STT - State Street EPS beats by $0.11, beats on revenue https://seekingalpha.com/news/3506839-state-street-eps-beats-0_11-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3506839-state-street-eps-beats-0_11-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506831\" data-ts=\"1571397819\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFIX\" target=\"_blank\">SFIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506831-telsey-expects-stitch-fix-to-run-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telsey expects Stitch Fix to run higher</a></h4><ul> <li>Stitch Fix (NASDAQ:<a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a>) is on watch after Telsey initiates coverage with an Outperform rating.</li> <li>The firm thinks the revenue growth story is still alive with Stitch Fix and expects positive free cash flow.</li> <li>Telsey assigns a price target of $29 to SFIX vs. the 52-week range of $16.05 to $37.72 and the sell-side consensus PT of <a href=\"https://seekingalpha.com/symbol/SFIX/ratings/sell-side-ratings\" target=\"_blank\">$27.00</a>. <a href=\"https://seekingalpha.com/symbol/SFIX/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha authors</a> also have a Bullish stance on the retailer.</li> <li>SFIX <font color=\"green\">+0.81%</font> premarket to $23.60.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506831\" data-linked=\"Telsey expects Stitch Fix to run higher\" data-tweet=\"$SFIX - Telsey expects Stitch Fix to run higher https://seekingalpha.com/news/3506831-telsey-expects-stitch-fix-to-run-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3506831-telsey-expects-stitch-fix-to-run-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506827\" data-ts=\"1571397102\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KO\" target=\"_blank\">KO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506827-comparable-sales-shine-coca-cola\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comparable sales shine at Coca-Cola</a></h4><ul> <li>Coca-Cola (NYSE:<a href='https://seekingalpha.com/symbol/KO' title='The Coca-Cola Company'>KO</a>) trades higher after reporting <a href=\"https://seekingalpha.com/pr/17667123-coca-cola-reports-continued-strong-results-third-quarter-updates-full-year-guidance\" target=\"_blank\">Q3</a> organic sales growth of +5% vs. +4.1% consensus. The solid quarter included 3% organic sales growth in North America and Asia Pacific. as well as a 4% gain for the EMEA region. Strong comps were turned in by the Latin America (+12), Global Ventures (+14%) and Bottling (+9%) segments.</li> <li>EPS matched consensus estimates despite a 6 bp F/X headwind. Comparable operating margin fell to 28.1% during the quarter from 30.7% a year ago.</li>  <li>The beverage giant reaffirmed full-year guidance for organic revenue up at least 5% and EPS growth of -1% to +1%. Capital expenditures of $2.2B expected vs. $2.4B prior guidance and $2.24B consensus.</li> <li>Shares of Coca-Cola are <font color=\"green\">up 1.49%</font> premarket to $54.59.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3506815-coca-cola-eps-line-beats-revenue\" target=\"_blank\">Coca-Cola EPS in-line, beats on revenue</a> (Oct. 18)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506827\" data-linked=\"Comparable sales shine at Coca-Cola\" data-tweet=\"$KO - Comparable sales shine at Coca-Cola https://seekingalpha.com/news/3506827-comparable-sales-shine-coca-cola?source=tweet\" data-url=\"https://seekingalpha.com/news/3506827-comparable-sales-shine-coca-cola\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506822\" data-ts=\"1571396559\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506822-chipotle-shakes-off-bear-rating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chipotle shakes off a bear rating</a></h4><ul> <li>Bank of America Merrill Lynch shifts to a Neutral position on Chipotle (NYSE:<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a>) after having the restaurant stock slotted at Underperform.</li> <li>\"While we still struggle with the valuation upside, our expectations that CMG will deliver near-term EPS upside to consensus makes a correction in the multiple unlikely, driving our decision to move to Neutral,\" reasons the firm.</li> <li>BAML doesn't expect a return to peak margins for Chipotle, but thinks strong comparable sales and EPS growth should support valuation.</li> <li>BAML moves to a price objective of $850 from $590 (50X the 2020 EPS estimate).</li> <li>Shares of Chipotle are <font color=\"green\">up 1.20%</font> premarket to $839.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3506822\" data-linked=\"Chipotle shakes off a bear rating\" data-tweet=\"$CMG - Chipotle shakes off a bear rating https://seekingalpha.com/news/3506822-chipotle-shakes-off-bear-rating?source=tweet\" data-url=\"https://seekingalpha.com/news/3506822-chipotle-shakes-off-bear-rating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506815\" data-ts=\"1571396372\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KO\" target=\"_blank\">KO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506815-coca-cola-eps-in-line-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coca-Cola EPS in-line, beats on revenue</a></h4><ul><li>Coca-Cola (NYSE:<a href='https://seekingalpha.com/symbol/KO' title='The Coca-Cola Company'>KO</a>): Q3 Non-GAAP EPS of $0.56 in-line; GAAP EPS of $0.60 <font color=\"green\">beats by $0.04</font>.</li><li>Revenue of $9.5B (+8.0% Y/Y) <font color=\"green\">beats by $80M</font>.</li><li>Shares <font color=\"green\">+2.27%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17667123-coca-cola-reports-continued-strong-results-third-quarter-updates-full-year-guidance\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3506815\" data-linked=\"Coca-Cola EPS in-line, beats on revenue\" data-tweet=\"$KO - Coca-Cola EPS in-line, beats on revenue https://seekingalpha.com/news/3506815-coca-cola-eps-in-line-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3506815-coca-cola-eps-in-line-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506806\" data-ts=\"1571395501\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDHL\" target=\"_blank\">RDHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506806-redhill-bio-in-licenses-cosmo-pharmas-aemcolo-rights-in-u-s-shares-up-10-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RedHill Bio in-licenses Cosmo Pharma&#39;s Aemcolo rights in U.S; shares up 10% premarket</a></h4><ul> <li>RedHill Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/RDHL' title='RedHill Biopharma Ltd.'>RDHL</a>) is up <font color=\"green\">10%</font> premarket after <a href=\"https://seekingalpha.com/pr/17667095-redhill-biopharma-announces-36-million-strategic-investment-cosmo-pharmaceuticals-u-s-rights\" target=\"_blank\">entering</a> into an exclusive license agreement with Cosmo Pharmaceuticals N.V. (<a href='https://seekingalpha.com/symbol/CMOPF' title='Cosmo Pharmaceuticals N.V.'>OTC:CMOPF</a>) for U.S. rights to Aemcolo (rifamycin) for Traveler\u2019s Diarrhea and a simultaneous private investment by Cosmo of $36.3M in RedHill.</li>        <li>As part of the Aemcolo license agreement, RedHill will issue Cosmo 1,714,286 ADSs at $7/ADS at an agreed value of $12M, as an upfront payment.</li><li>These ADSs are in addition to the ADSs issued to Cosmo as part of the $36.3M investment. In addition, RedHill will pay a royalty percentage in the high twenties on net sales of Aemcolo in U.S.</li><li>The license agreement further provides for potential milestone payments to Cosmo totaling up to $100M.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3506806\" data-linked=\"RedHill Bio in-licenses Cosmo Pharma&#39;s Aemcolo rights in U.S; shares up 10% premarket\" data-tweet=\"$RDHL $CMOPF - RedHill Bio in-licenses Cosmo Pharma&#39;s Aemcolo rights in U.S; shares up 10% premarket https://seekingalpha.com/news/3506806-redhill-bio-in-licenses-cosmo-pharmas-aemcolo-rights-in-u-s-shares-up-10-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3506806-redhill-bio-in-licenses-cosmo-pharmas-aemcolo-rights-in-u-s-shares-up-10-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506805\" data-ts=\"1571395326\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNSDF\" target=\"_blank\">RNSDF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506805-renaultminus-12-after-profit-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Renault -12% after profit warning</a></h4><ul> <li>Shares of Renault (<a href='https://seekingalpha.com/symbol/RNSDF' title='Renault SA'>OTC:RNSDF</a>) are down sharply in Paris after yesterday's post-close earnings warning from the automaker rattled investors.</li> <li>Renault execs pointed to difficulties in Argentina and Turkey as contributing factors in the reduced organic sales outlook.</li> <li>\"Needless to say that this profit warning comes at a time of major instability at Renault and its partner Nissan. Investor worries will more likely intensify,\" <a href=\"https://www.reuters.com/article/us-renault-results/renault-shares-plunge-as-profit-warning-deepens-its-problems-idUSKBN1WX0O6?feedType=RSS&amp;feedName=businessNews\" target=\"_blank\">notes</a> Evercore on the development.</li> <li>Renault is <font color=\"red\">down 12.17%</font> in Paris trading at last check.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3506607-renault-lowers-full-year-outlook\" target=\"_blank\">Renault lowers full-year outlook</a> (Oct. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3506805\" data-linked=\"Renault -12% after profit warning\" data-tweet=\"$RNSDF - Renault -12% after profit warning https://seekingalpha.com/news/3506805-renaultminus-12-after-profit-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3506805-renaultminus-12-after-profit-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3506798\" data-ts=\"1571393449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDFC\" target=\"_blank\">WDFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3506798-wdminus-40-down-5_3-premarket-fy2020-outlook-lower-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WD-40 down 5.3% premarket as FY2020 outlook lower than consensus</a></h4><ul><li>WD-40 (NASDAQ:<a href='https://seekingalpha.com/symbol/WDFC' title='WD-40 Company'>WDFC</a>) slips <font color=\"red\">~5.3%</font> premarket on lower FY2020 EPS outlook of $4.74 to $4.83 vs. $4.98 consensus and revenue of $436M to $453M vs. $444M consensus.</li><li>Net sales by segment: Americas: $49.32M (+1%); EMEA: $36.36M (-1%); Asia-Pacific: $21.07M (+22%).</li><li>Gross margin rate improved 60 bps to 54.6%.</li><li>Maintenance products sales increased 4% to $97.27M.</li><li>Homecare and cleaning products sales down 0.4% to $9.47M.</li><li>GAAP net income declined 60% Y/Y to $8.6M for the quarter.</li><li><strong>FY2020 Guidance</strong>: Net sales: $436M to $453M (+3% to +7%); Gross margin rate: 54% to 55%; Advertising and promotion investments expense rate: 5.5% to 6%; Tax: 20% to 22%; Net income: $65M to $66.2M; Diluted EPS: $4.74 to $4.83; Weighted average shares outstanding: 13.7M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3506680-wdminus-40-eps-beats-0_02-beats-revenue\" target=\"_blank\">WD-40 EPS beats by $0.02, beats on revenue</a> (Oct. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3506798\" data-linked=\"WD-40 down 5.3% premarket as FY2020 outlook lower than consensus\" data-tweet=\"$WDFC - WD-40 down 5.3% premarket as FY2020 outlook lower than consensus https://seekingalpha.com/news/3506798-wdminus-40-down-5_3-premarket-fy2020-outlook-lower-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3506798-wdminus-40-down-5_3-premarket-fy2020-outlook-lower-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":65,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}